| |
original article |
Journal |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
Cancer Research |
2024―Mar―22 |
Abstract 4827: Financial toxicity among cancer survivors during the COVID-19 pandemic |
Tanvi Srivastava, Salma Shariff-Marco, Samuel L. Washington, Christine Miaskowski, June M. Chan |
| 2 |
[GO] |
Cancer Research |
2024―Mar―22 |
Abstract 1295: CancerCare coping circle workshop for patients with cancer and covid-19 |
Christine Verini, Sarah Paul, Rebecca Ashkenazy, Brittany Wolf Gianares |
| 3 |
[GO] |
Cancer Research |
2024―Mar―22 |
Abstract 4797: Impact of COVID-19 pandemic on breast cancer screening and diagnosis stage in a large midwestern United States academic medical center |
Kimberly J. Johnson, RJ Waken, Caitlin P. O'Connell, Derek Brown |
| 4 |
[GO] |
Cancer Research |
2024―Mar―22 |
Abstract 787: SARS-COV-2 P.1 strain infection in lung, breast and colon tumoral patient-derived organoids |
Tayanne F. Sassaro, Anael Viana, Mariano Zalis, Carlos Gil Moreira Ferreira, Jorge Canedo, Danielle Ferreira, Aline S. Moreira, Elen Mello, Fabiana Rondão, Beatriz I. Ferreira, Otacilio C. Moreira, Daniel A. Moreira, Bruno Souza, Mariana C. Waghabi, Tatiana M. Tilli |
| 5 |
[GO] |
Cancer Research |
2024―Jan―16 |
Abstract A013: Uptake and predictors of Covid-19 vaccination among United States’ cancer populations |
Tayla Greene, Kikelomo Olaosebikan, Osahon Idolor, James Appiah-Pippim |
| 6 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Dec―21 |
SARS-CoV-2 Infection and Related Hospitalization Among Cancer Survivors |
Larissa L. White, Andrea N. Burnett-Hartman, Laura E. Ichikawa, Shauna R. Goldberg, Jessica Chubak, Heather Spencer Feigelson, Aruna Kamineni |
| 7 |
[GO] |
Molecular Cancer Research |
2023―Dec―08 |
Single-cell transcriptomics reveals pre-existing COVID-19 vulnerability factors in lung cancer patients |
Wendao Liu, Wenbo Li, Zhongming Zhao |
| 8 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Dec―01 |
Abstract C127: Strategies to improve breast cancer screenings among uninsured individuals post COVID-19 |
Evelyn Robles-Rodriguez, Plyshette Wiggins, Tondalya DeShields |
| 9 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Dec―01 |
Abstract B024: Engaging rural male cancer survivors during COVID-19 |
Jala Lockhart, Levi Ross, Vanessa B. Sheppard, Michael A. Preston |
| 10 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Dec―01 |
Abstract A008: Addressing medical distrust among African Americans and adherence to cancer screening recommendations during COVID-19 |
Finie Hunter-Richardson, Pamela L. Carter-Nolan, Carla D. Williams, Mark S. Johnson |
| 11 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Dec―01 |
Abstract C129: Impact of COVID-19 on colorectal cancer screening disparities: Results from a large commercially insured population in the United States |
Arfan Siddique, Rong Wang, Jacquelyne Gaddy, Cary Gross, Xiaomei Ma |
| 12 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Dec―01 |
Abstract A108: Perceived negative effects of COVID-19 on mental health based on a history of cancer |
Meng Chen, Dina K. Abouelella, Melissa C. White, Rong Jiang, Oluwole A. Babtunde, Eric Adjei Boakye, Tammara L. Watts, Nosayaba Osazuwa-Peters |
| 13 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Dec―01 |
Abstract A095: Rural disparities in telemedicine use among cancer survivors during the COVID-19 pandemic |
Minjee Lee, Meng-Han Tsai |
| 14 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Dec―01 |
Abstract B045: Effect of the COVID-19 pandemic on disparities in stage of breast cancer diagnosis |
Ruvarashe P. Rumano, Nicci Owusu-Brackett, Akia Clarke, Robert Tamer, Elizabeth Ghias, Jesse Plascak, Electra D. Paskett, Bridgett A. Oppong |
| 15 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Dec―01 |
Abstract B129: The association of Covid-19 pandemic restrictions with patient-reported outcomes and lifestyle behaviors among breast cancer survivors: Evidence from a cohort of Black and Hispanic breast cancer survivors in New Jersey |
Carola T. Sanchez-Diaz, Nur Zeinomar, Hari S. Iyer, Marley Perlstein, Chi-Chen Hong, Bo Qin, Elisa V. Bandera |
| 16 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Dec―01 |
Abstract C131: Disparities in breast cancer screening resumption among health plan enrollees in the US following the COVID-19 pandemic: Are all groups back on track? |
Jennifer Tsui, Sarah Axeen, John Thacker, Sonali Saluja, Laura Solano, Willow Pastard, Chun Nok Lam, Todd Schneberk, Cameron Kaplan |
| 17 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Aug―18 |
Impact on the Volume of Pathology Reports Before and During the COVID-19 Pandemic in SEER Cancer Registries |
Amina Chtourou, Pamela V. Sanchez, Todd Golden, Huann-Sheng Chen, Stephen M. Schwartz, Xiao-Cheng Wu, Brenda Y. Hernandez, Jovanka N. Harrison, Lynne Penberthy, Serban Negoita |
| 18 |
[GO] |
Cancer Research |
2023―Jun―09 |
Abstract 5523: Impact of COVID-19 on longitudinal breast cancer research studies involving TNBC patients |
Cherie Bates, Esther Kong, Elena Zaikova, Samuel Aparicio, Karen Gelmon |
| 19 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jun―01 |
Abstract 80: The Impact of Covid-19 Pandemic in Colonoscopies and Colorectal, Rectosigmoid and Anal Cancer Screening |
Rafaela de Andrade, Gabriele Eckerdt Lech, Pedro Antonio Paludo Menna Barreto, Arthur Minas Alberti, Luiza Seixas de Sá Beltramo, Fernando Azambuja, Laura Tibola Marques da Silva, Lucas Kieling, Pedro Arthur Zimmer Silveira |
| 20 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jun―01 |
Abstract 79: The Impact of COVID-19 on HPV Immunization Programs in Countries With High Cervical Cancer Burdens: Global and National Perspectives |
Dominique Guillaume, Due-e-Nayab Waheed, Mieke Schlieff, Kirthini Muralidharan, Alex Vorsters, Rupali Limaye |
| 21 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jun―01 |
Abstract 51: Impacts of the COVID-19 Pandemic on Pediatric and Adolescent Cancer Care in Northern Tanzania |
Hannah Rice, Esther Majaliwa, Cesia Cotache-Condor, Yotham Gwanika, Nelson Chao, Kristin Schroeder, Henry Rice, Catherine Staton, Blandina Mmbaga, Emily Smith |
| 22 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jun―01 |
Abstract 50: Impact of the COVID-19 Pandemic on Breast Cancer Treatments in the Brazilian Public System |
Laura Tibola Marques da Silva, Pedro Antonio Paludo Menna Barreto, Luiza Seixas de Sá Beltramo, Gabriele Eckerdt Lech, Fernando Azambuja, Rafaela de Andrade, Arthur Minas Alberti, Pedro Arthur Zimmer Silveira, Lucas Kieling |
| 23 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jun―01 |
Abstract 45: How Did States Adapt Their Cancer Control Plan During the COVID-19 Pandemic? |
Jason Semprini |
| 24 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jun―01 |
Abstract 68: Preparing for the Next Pandemic: An Asian National Cancer Centers Alliance (ANCCA) Initiative |
Sok King Ong, Laureline Gatellier, Tomohiro Matsuda |
| 25 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―May―02 |
Updated Review of Major Cancer Risk Factors and Screening Test Use in the United States, with a Focus on Changes During the COVID-19 Pandemic |
Jessica Star, Priti Bandi, Nigar Nargis, Farhad Islami, K Robin Yabroff, Adair K. Minihan, Robert A. Smith, Ahmedin Jemal |
| 26 |
[GO] |
Blood Cancer Discovery |
2023―Apr―20 |
Defective Immunity Against SARS-CoV-2 Omicron Variants Despite Full Vaccination in Hematologic Malignancies |
Laurence Zitvogel, Lisa Derosa, Guido Kroemer |
| 27 |
[GO] |
Cancer Research |
2023―Apr―14 |
Abstract LB054: Establishment of an infrastructure for rapid pandemic response at the Frederick National Laboratory |
Nancy V. Roche, Troy Kemp, Ligia Pinto, Tom Hickey |
| 28 |
[GO] |
Cancer Research |
2023―Apr―05 |
Abstract 5590: Liquid biopsy testing in metastatic or advanced breast cancer patients during the COVID-19 pandemic |
Benjamin L. Furman, Ebru Baran, Sonal Brahmbhatt, Betty Chan, Ka Mun Nip, Adrian Kense, Brenda Murphy, Vincent Funari, David G. Huntsman, Ruth Miller, Melissa K. McConechy |
| 29 |
[GO] |
Cancer Research |
2023―Apr―04 |
Abstract 794: Repurposing of poly-γ-glutamic acid, immunotherapeutic drug for cervical intraepithelial neoplasia 1, as covid-19 treatment |
Chan-Hee Yoo, Jae Chul Choi, Do Young Lee, Chun-Soo Lee, Young-Chul Park |
| 30 |
[GO] |
Cancer Research |
2023―Apr―04 |
Abstract 795: T-cell mediated response to emerging COVID-19 strains in patients with cancer studied via deep learning |
Olga Lyudovyk, Yuval Elhanati, Artem Streltsov, Quaid Morris, Santosha Vardhana, Benjamin Greenbaum |
| 31 |
[GO] |
Cancer Research |
2023―Apr―04 |
Abstract 799: Measuring the impact of the COVID-19 pandemic on breast cancer screening in Puerto Rico |
Vivian Colón-López, Hermilis Berrios Ortiz, Hector Contreras-Mora, Orville M. Disdier, Cynthia M. Pérez, Nilda Ríos, Olga L. Díaz, Juan Mejías, Erick L. Suárez-Pérez |
| 32 |
[GO] |
Cancer Research |
2023―Apr―04 |
Abstract 800: Participation in COVID-19 clinical trials, willingness to participate, and trust in sources of information among persons with and without cancer in Puerto Rico. |
Fabiola A. Rivera-Gastón, Hérmilis Berríos-Ortiz, Jeslie M. Ramos-Cartagena, Andrea López-Cepero, Vivian Colón-López, Cynthia M. Pérez, Ana P. Ortiz |
| 33 |
[GO] |
Cancer Research |
2023―Apr―04 |
Abstract 801: The impact of COVID-19 on colorectal screening in Puerto Rico |
Héctor M. Contreras-Mora, Erick L. Suárez-Pérez, Cynthia M. Pérez, Hérmilis Berríos-Ortiz, Orville M. Disdier, Nilda Ríos, Olga L. Díaz, Juan Mejías, Vivian Colón-López |
| 34 |
[GO] |
Cancer Research |
2023―Apr―04 |
Abstract 806: Enhancer deregulation inTET2-mutant clonal hematopoiesis is associated with increased COVID-19 severity and mortality |
Moritz Binder, Terra L. Lasho, Wazim Mohammed Ismail, Nana A. Ben-Crentsil, Jenna A. Fernandez, Minsuk Kim, Susan M. Geyer, Amelia Mazzone, Christy M. Finke, Abhishek A. Mangaonkar, Jeong-Heon Lee, Kwan Hyun Kim, Vernadette A. Simon, Fariborz Rakhshan Rohakthar, Amik Munankarmy, Susan M. Schwager, Jonathan J. Harrington, Melissa R. Snyder, Nathalie M. Droin, Eric Solary, Keith D. Robertson, Eric D. Wieben, Eric Padron, Nicholas Chia, Alexandre Gaspar-Maia, Mrinal M. Patnaik |
| 35 |
[GO] |
Cancer Research |
2023―Apr―04 |
Abstract 797: COVID-19 vaccines in patients with solid tumor cancers receiving immune checkpoint inhibitors |
Danielle Gilbert, Junxiao Hu, Elaine T. Lam |
| 36 |
[GO] |
Cancer Research |
2023―Apr―04 |
Abstract 804: The temporal evolution in disease phenotype of COVID-19 hospitalisation, intensive care and case fatality rates in cancer patients across the United Kingdom (UKCCP) |
Thomas Starkey, Maria C. Ionescu, Matthew W. Fittall, Michael Tilby, Alex Burnett, Rosie Hattersley, Sam Khan, Martin Little, Justin K. Liu, James R. Platt, Arvind Tripathy, Isabella Watts, Sophie Therese Williams, United Kingdom COVID Cancer Programme, Tom Fowler, Peter W. Johnson, Lennard Y. Lee |
| 37 |
[GO] |
Cancer Research |
2023―Apr―04 |
Abstract 805: Association of state-level COVID-19 mortality rates with real-world progression and real-world overall survival among patients with advanced non-small cell lung cancer, 2020-2022 |
Maneet Kaur, Christina M. Parrinello, Jenny S. Guadamuz, Trevor J. Royce, Gregory S. Calip |
| 38 |
[GO] |
Cancer Research |
2023―Apr―04 |
Abstract 807: Inflammatory biomarkers: Breast cancer survival and possible role in COVID-19 associated comorbidity |
Alakesh Bera, Eric Russ, Surya Radhakrishnan, Hai Hu, COL Craig D. Shriver, Meera Srivastava |
| 39 |
[GO] |
Cancer Research |
2023―Apr―04 |
Abstract 787: Lung cancer screening use before & during the COVID-19 pandemic in the US: Population-based evidence from 2019-2021 |
Hermine Poghosyan, Sayantani Sarkar, Ilana Richman |
| 40 |
[GO] |
Cancer Research |
2023―Apr―04 |
Abstract 792: SARS-CoV-2 spike S1 mediated lung tumor regression in a mouse model |
Monica Sheinin, Kalipada Pahan, Ramesh K. Paidi |
| 41 |
[GO] |
Cancer Research |
2023―Apr―04 |
Abstract 802: Identifying factors that affect barriers to lymphoma treatment during the COVID - 19 pandemic |
Cherie D. Bates, Steve E. Kalloger, Lorna E. Warwick |
| 42 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P3-03-11: Racial and Ethnic Disparities in Screening Mammography During COVID-19 |
Arissa Milton, Ryan Woods, Mai Elezaby, Kelly Hackett, Joan Neuner, Anand Narayan, Roberta Strigel |
| 43 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P4-03-36: Determinants of severe COVID-19 infection in Patients with Breast Cancer from a Community Oncology Practice in Brazil |
Fanny Cascelli, Matheus Costa e Silva, Rodrigo Dienstmann, Bruno L. Ferrari, Carlos Gil Ferreira, Max S. Mano, Jorge Canedo, Diego Cunha, Daniel Luiz Gimenes, Aline Goncalves |
| 44 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P1-05-20: COVID-19 Lockdown Resulting in Advanced Cancer and Worse Histology at Presentation in Hispanics |
Juzar Hussain, Gabriel Roman Souza, Tamarah Aldawoodi, Lauren C. Jameson, Lauren Rahman, Nomso C. Agim, Jonathan Gelfond, Marcela Mazo-Canola |
| 45 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P6-05-13: The Psychological Impacts of COVID-19 on Breast Cancer Patients in China |
Yijia Wang, Yuqing Yang, Changjiao Yan, Jixin Yang, Hongliang Wei, Wen Ma, Nanlin Li |
| 46 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P4-03-25: Patient-level predictors of skipping screening mammograms during the COVID-19 pandemic at a large tertiary care center in Texas |
Maryam Nemati Shafaee, Omar Rosales, Randall Parker Kirby, Tamara Ortiz-Perez, Luke Gilman, Ashley Hardeman, Preeya Bhavsar Bhakta, Chris Amos, Abiodun Oluyomi |
| 47 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P1-05-22: The Impact of the COVID-19 Pandemic on Breast Cancer Diagnoses in San Antonio, TX |
Gabriel Roman Souza, Tamarah Aldawoodi, Juzar Hussain, Lauren C. Jameson, Lauren Rahman, Nomso C. Agim, Jonathan Gelfond, Marcela Mazo-Canola |
| 48 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P4-03-29: Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway |
Anouk Eijkelboom, Linda de Munck, Marthe Larsen, Jan Nygård, Solveig Hofvind, Sabine Siesling |
| 49 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P1-05-19: Impact of the COVID-19 pandemic on the diagnostic pathway of breast cancer in the Netherlands: a population-based study |
Wouter Wolfkamp, Joyce Meijer, Jolanda Van Hoeve, Jeroen Veltman, Sabine Siesling |
| 50 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P1-05-21: Change in breast cancer detection method, stage at diagnosis and treatment during the COVID-19 Pandemic: 2019-2021 |
Judith A. Malmgren, Mary Atwood, Henry Kaplan |
| 51 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P5-03-16: Changes in preferences for ovarian cancer prevention strategies during the COVID-19 pandemic: Results of a discrete choice experiment |
Brian Egleston, Mary Daly, Kaitlyn Lew, Lisa Bealin, Alexander Husband, Jill Stopfer, Pawel Przybysz, Olga Tchuvatkina, Yu-Ning Wong, Judy Garber, Timothy Rebbeck |
| 52 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P6-08-07: Reasons for Reduced Willingness to Participate in Clinical Trials During the COVID-19 Pandemic: The Translational Breast Cancer Research Consortium (TBCRC) 057 Survey |
Karen L. Smith, Carolyn Mead-Harvey, Gina L. Mazza, Albert E. Holler, Eileen Shinn, Elizabeth Frank, Michelle Melisko, Cyd Eaton, Jeannine M. Salamone, Teri Pollastro, Patricia Spears, Antonio C. Wolff, Gabrielle B. Rocque |
| 53 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P1-12-04: Side Effects of the mRNA COVID-19 Vaccines in Women Treated for Breast Cancer |
Brooke Juhel, Cheryl L. Brunelle, Madison C. Bernstein, Louisa H. Smith, Amanda W. Jung, Elizabeth K. Hausman, Loryn K. Bucci, George E. Naoum, Alphonse G. Taghian |
| 54 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P6-05-19: Racial Disparities in the Quality of Life and Vaccination of Breast Cancer Survivors during COVID-19: A Longitudinal Study |
Fangyuan Zhao, Brenda L. Copley, Sondra H. Birch, Rita Nanda, Olufunmilayo I. Olopade, Dezheng Huo |
| 55 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P3-03-04: Cyclin-dependent kinase 4/6 inhibitor in advanced breast cancer during the COVID pandemic period: efficacy in relation to vaccination for SARS-COV 19 |
Filippo Giovanardi, Edoardo Carretto, Giancarlo Bisagni, Claudia Degli Esposti, Elisa Gasparini, Alessandra Bologna, Roberto Di Cicilia, Gabriella Moretti, Carmine Pinto |
| 56 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P1-06-06: Access to medical coverage in newly diagnosed Breast cancer patients a minority population during the COVID 19 pandemic |
Tamarah Aldawoodi, Gabriel Roman Souza, Juzar Hussain, Lauren C. Jameson, Lauren Rahman, Nomso C. Agim, Jonathan Gelfond, Marcela Mazo-Canola |
| 57 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P6-05-45: Providing Educational Resources during the Pandemic for Advanced Breast Cancer Patients |
Ginny T. Kirklin, Abbey Kaler, Debu Tripathy |
| 58 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P3-03-01: The impact of the COVID19 pandemic on treatment practices for patients diagnosed with early breast cancer: a cross-sectional study from a large comprehensive cancer centre in Italy |
Fabio Girardi, Sabrina Marini, Francesca Porra, Ilaria Mietto, Sonia Carpentieri, Alberto Marchet, Tania Saibene, Marcello Lo Mele, Tommaso Giarratano, Carlo Alberto Giorgi, Eleonora Mioranza, Cristina Falci, Giovanni Faggioni, Francesca Caumo, Gaia Griguolo, Maria Vittoria Dieci, Valentina Guarneri |
| 59 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P6-05-51: Best Quality of Care from a Distance (BQual-D): Maintaining high quality care for hormone receptor positive (HR+) metastatic breast cancer (MBC) during the COVID pandemic, patient participation and satisfaction with the program |
Gretchen Kimmick, Smrithi Divakaran, Heather Moore, Cynthia Rose, Pamela Gentry, Michael Willis, Susan Dent, Sarah L. Sammons, Jeremy Force, Kelly Westbrook, Carey Anders, Rebecca Shelby |
| 60 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P6-08-13: Home-based treatment with subcutaneous (SC) trastuzumab - only a pandemic solution? Real world evidence (RWE) analysis |
Barbara Radecka, Hudała-Klecha Joanna, Dariusz Sawka, Jolanta Sarga, Bożena Noworolska, Jolanta Sawicka, Elżbieta Duda, Natalia Obruśnik, Patryk Zając |
| 61 |
[GO] |
Cancer Research |
2023―Mar―02 |
Abstract P4-05-03: Investigating Financial Toxicity among Breast Cancer Patients Diagnosed during the Pandemic: The Role of Cancer Care Disruptions and Social Isolation |
Chiara Acquati, Tzuan Chen, Isabel Martinez Leal, Shahnjayla Connors, Anastasia Rogova, Mathew Banegas, Grace Smith, Lorraine R. Reitzel, Lorna McNeill |
| 62 |
[GO] |
Cancer Research Communications |
2023―Jan―26 |
MEASURING THE IMPACT OF THE COVID-19 PANDEMIC ON HEALTH BEHAVIORS AND HEALTHCARE UTILIZATION IN RURAL AND URBAN CANCER PATIENTS AND CANCER SURVIVORS |
Alison Cole, C. Holly A. Andrilla, Davis G Patterson, Sarah Davidson, Jason A Mendoza |
| 63 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jan―10 |
COVID-19 outcomes by cancer status, site, treatment, and vaccination |
Maxwell Salvatore, Miriam M. Hu, Lauren J. Beesley, Alison M. Mondul, Celeste Leigh. Pearce, Christopher R. Friese, Lars G. Fritsche, Bhramar Mukherjee |
| 64 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jan―09 |
Abstract B123: Prevalence of COVID-19 among hematology/oncology patients and providers of a community-facing county health system during the B1.1.529 (“Omicron”) SARS-CoV-2 variant wave |
Aliya Khan, Samuel A. Kareff, Priscila Barreto-Coelho, Sunil Iyer, Brian Pico, Michele Stanchina, Giselle Dutcher, José Monteiro de Oliveira Novaes, Aparna Nallagangula, Gilberto Lopes |
| 65 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jan―09 |
Abstract B020: “Access to these screenings have been a gift”: A mixed methods assessment of a community navigation program for breast and cervical in the era of COVID-19 |
Leslie R. Carnahan, Chibuzor Abalsalim, Jeanette Santana González, Mari Goudy, Hunter Holt, Jessica Madrigal, Thrishka McKinnor, Tigist Mersha, Theresa Mobley, Maria Olivero, Mary Rinder, Barbara Williams, Vida Henderson |
| 66 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jan―09 |
The Importance of Recency of Cancer Diagnosis in Patients Hospitalized with COVID-19-Glimpses from an EHR-based Study |
Pamela C. Egan, Chinmay Jani, Harpreet Singh, Sanjay Mishra, Jeremy L. Warner |
| 67 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jan―09 |
Abstract C130: Cervical, breast, and colorectal cancer screening by COVID-19 booster and influenza vaccination status in a sample of women in Puerto Rico |
Katherine A. Hill, Cynthia M. Pérez, Adriana Pons, Karelys Canales Birriel, Andrea López Cepero, Norangelys Solís Torres, Zaydelis Tamarit Quevedo, Vivian Colón-López |
| 68 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jan―09 |
Abstract B024: Pivot to SPARCC diversity in the clinical cancer research workforce; implementation and evaluation of an academic enrichment pathway before, during, and after the COVID-19 global pandemic |
Kristina Kaljo, Lindsey McAlarnen, Michael Braun, Emmanuel Ngui, Janet S. Rader |
| 69 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jan―09 |
Abstract C103: Inequities in timely cancer treatment after testing positive for COVID-19: Findings from the ASCO Survey on COVID-19 in Oncology (ASCO) Registry |
Adana A.M. Llanos, Adiba Ashrafi, Nabarun Ghosh, Jennifer Tsui, Yong Lin, Angela J. Fong, Shridar Ganesan, Carolyn J. Heckman |
| 70 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jan―09 |
Abstract B087: Disparities in pediatric patients receiving proton therapy during the COVID-19 pandemic - A single institutional experience |
Samuel P. McKinnon, Zara I. Kazmierczak, Arthur J. Olch, Daniel Roh, Ethan Nguyen, Kristen Pang, Iain J. MacEwan, Kenneth K. Wong |
| 71 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jan―09 |
Abstract B060: Increasing breast and cervical cancer knowledge in the COVID-19 pandemic in the health system |
Omayra Salgado-Cruz, Nelybeth Santiago-Yance, Mirza Rivera-Lugo, Guillermo Tortolero-Luna |
| 72 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jan―09 |
Abstract A053: Assessing the impact of the COVID-19 pandemic on a statewide breast and cervical cancer safety net screening and diagnostic program: Are there differences by rural - urban geography? |
Leslie R. Carnahan, Ananya Stoller, William Barshop, Genevieve Rizzo, Arden Handler |
| 73 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jan―09 |
Abstract A096: Stakeholders’ perceptions on the impact of the COVID-19 pandemic on the implementation of the HPV vaccine school-entry requirement in Puerto Rico |
Coralia Vázquez-Otero, Diana T. Medina-Laabes, Derick Pérez-Guzmán, Olga L. Díaz-Miranda, VOCES PR, Vivian Colón-Lopez |
| 74 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jan―09 |
Abstract B037: Effective recruitment strategies utilized in the midst of a COVID-19 pandemic to examine dietary practices and colorectal cancer screening practices of Blacks in New York City |
Cicely K. Johnson, Grace X. Ma, May May Leung, Olorunseun O. Ogunwobi |
| 75 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jan―09 |
Abstract A090: Overcoming racial and ethnic disparities in cancer clinical trial accrual during the COVID-19 pandemic: A partnership between a cancer center’s clinical trials office and community outreach and engagement |
Jesse Nodora |
| 76 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jan―09 |
Abstract A025: HPV and COVID-19 vaccines attitudes and preferred sources of information among adults living in Puerto Rico |
Jessica N. Rivera-Rivera, Olga L. Díaz-Miranda, Diana T. Medina-Laabes, Erick Suárez, Ana P. Ortiz, Vivian Colón-López |
| 77 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jan―09 |
Abstract C120: Are there racial disparities in the incidence of venous thromboembolism (VTE) in hospitalized cancer patients with COVID-19? |
Adnan Khan, Chun-Hui Lin, Sheela Tejwani |
| 78 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2023―Jan―09 |
Abstract A048: Pandemic effects on social capital and loneliness in residents and non-residents of Chinese immigrant enclaves in Philadelphia |
Marilyn Tseng, Brian Egleston, Julia Zhong, Minzi Li, Carolyn Fang |
| 79 |
[GO] |
Cancer Prevention Research |
2023―Jan―04 |
Abstract P019: Continued depression of breast and lung cancer screening among Medicare enrollees during the COVID-19 pandemic |
Christopher Huy D. Doan, Shuang Li, James Goodwin |
| 80 |
[GO] |
Blood Cancer Discovery |
2022―Dec―13 |
Impaired SARS-CoV-2 variant neutralization and CD8+ T cell responses following 3 doses of mRNA vaccines in myeloma: correlation with breakthrough infections |
Maryam I. Azeem, Ajay K. Nooka, Uma Shanmugasundaram, Narayanaiah Cheedarla, Sayalee Potdar, Renee Julia Manalo, Alberto Moreno, Jeffrey M. Switchenko, Suneethamma Cheedarla, Deon Bryant. Doxie, Roman Radzievski, Madison Leigh. Ellis, Kelly E. Manning, Bushra Wali, Rajesh M. Valanparambil, Kathryn T. Maples, Essence Baymon, Jonathan L. Kaufman, Craig C. Hofmeister, Nisha S. Joseph, Sagar Lonial, John D. Roback, Alessandro Sette, Rafi Ahmed, Mehul S. Suthar, Andrew S. Neish, Madhav V. Dhodapkar, Kavita M. Dhodapkar |
| 81 |
[GO] |
Cancer Research Communications |
2022―Dec―13 |
Antibody binding and neutralization of live SARS-CoV-2 variants including BA.4/5 following booster vaccination of patients with B-cell malignancies |
Andres Chang, Akil Akhtar, Lilin Lai, Victor M Orellana-Noia, Susanne L Linderman, Ashley A McCook-Veal, Jeffrey M Switchenko, Manpreet Saini, Rajesh M Valanparambil, Kristie A. Blum, Pamela B. Allen, Mary Jo Lechowicz, Jason T. Romancik, Amy Ayers, Alyssa Leal, Colin B O'Leary, Michael C. Churnetski, Katelin Baird, Melissa Kives, Jens Wrammert, Ajay K Nooka, Jean L. Koff, Madhav V Dhodapkar, Mehul S Suthar, Jonathon B. Cohen, Rafi Ahmed |
| 82 |
[GO] |
Cancer Immunology Research |
2022―Dec―02 |
Abstract A64: Mechanistic model for booster doses effectiveness in healthy, cancer and immunosuppressed patients infected with SARS-CoV-2 |
Chrysovalantis Voutouri, Corey C Hardin, Vivek Naranbhai, Mohammad R. Nikmaneshi, Melin J. Khandekar, Justin F Gainor, Triantafyllos Stylianopoulos, Lance L. Munn, Rakesh K. Jain |
| 83 |
[GO] |
Cancer Research |
2022―Dec―02 |
Abstract A019: Impact of COVID-19 on patient navigation services for follow-up colonoscopy after abnormal fecal testing in community health centers |
Jamie H. Thompson, Jennifer Rivelli, Jennifer Schneider, Amanda F. Petrik, Gloria D. Coronado |
| 84 |
[GO] |
Cancer Research |
2022―Nov―15 |
Abstract A048: Impact of COVID-19 on pancreatic cancer outcomes in Florida |
Guettchina Telisnor, Alexander S. Lim, Zhongyue Zhang, XiangYang Lou, Ibrahim Nassour, Bo Han, Edward Agyare, Sherise C. Rogers |
| 85 |
[GO] |
Clinical Cancer Research |
2022―Nov―07 |
Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients |
Yana Debie, Jonas R.M. Van Audenaerde, Timon Vandamme, Lieselot Croes, Laure-Anne Teuwen, Lise Verbruggen, Greetje Vanhoutte, Elly Marcq, Lisa Verheggen, Debbie Le Blon, Bart Peeters, Maria E. Goossens, Pieter Pannus, Kevin K. Ariën, Sébastien Anguille, Annelies Janssens, Hans Prenen, Evelien L.J. Smits, Christof Vulsteke, Eva Lion, Marc Peeters, Peter A. van Dam |
| 86 |
[GO] |
Cancer Research Communications |
2022―Nov―01 |
Boosting of waned humoral and cellular responses to SARS-CoV-2 variants-of-concern among cancer patients |
Duncan R McKenzie, Rosalind Graham, Thomas Lechmere, Clara Domingo-Vila, Thanussuyah Alaguthurai, Celeste Arman, Emily Pollock, Charalampos Gousis, Helen Kakkassery, Esme Carpenter, Ashwini Kurshan, Jennifer Vidler, Austin Kulasekararaj, Piers Patten, Bernard V. North, Timothy Tree, Katie J. Doores, Adrian C. Hayday, Sheeba Irshad |
| 87 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Oct―10 |
Impact and recovery from COVID-19-related disruptions in colorectal cancer screening and care in the US: A scenario analysis |
Rosita van den Puttelaar, Iris Lansdorp-Vogelaar, Anne I. Hahn, Carolyn M. Rutter, Theodore R. Levin, Ann G. Zauber, Reinier G S. Meester |
| 88 |
[GO] |
Blood Cancer Discovery |
2022―Sep―08 |
Anti-spike T cell and antibody responses to SARS-CoV-2 mRNA vaccines in patients with hematologic malignancies |
Lee M. Greenberger, Larry A. Saltzman, Lore M. Gruenbaum, Jun Xu, Sneha T. Reddy, Jonathon W. Senefeld, Patrick W. Johnson, Paul A. Fields, Catherine Sanders, Louis J. DeGennaro, Gwen L. Nichols |
| 89 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Aug―15 |
Relations of Current and Past Cancer with Severe Outcomes
among 104,590 Hospitalized COVID-19 Patients:
The COVID EHR Cohort at the University of Wisconsin |
Margaret B. Nolan, Thomas M. Piasecki, Stevens S. Smith, Timothy B. Baker, Michael C. Fiore, Robert T. Adsit, Daniel M. Bolt, Karen L. Conner, Steven L. Bernstein, Oliver D. Eng, David Lazuk, Alec Gonzalez, Todd Hayes-Birchler, Douglas E. Jorenby, Heather D'Angelo, Julie A. Kirsch, Brian S. Williams, Sean Kent, Hanna Kim, Stanley A. Lubanski, Menggang Yu, Youmi Suk, Yuxin Cai, Nitu Kashyap, Jomol Mathew, Gabriel McMahan, Betsy Rolland, Hilary A. Tindle, Graham W. Warren, Noor Abu-el-rub, Lawrence C. An, Andrew D. Boyd, Darlene H. Brunzell, Victor A. Carrillo, Li-Shiun Chen, James M. Davis, Vikrant G. Deshmukh, Deepika Dilip, Adam Goldstein, Patrick K. Ha, Eduardo Iturrate, Thulasee Jose, Niharika Khanna, Andrea King, Elizabeth Klass, Michelle Lui, Robin J. Mermelstein, Chester Poon, Elisa Tong, Karen M. Wilson, Wendy E. Theobald, Wendy S. Slutske |
| 90 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 435: COVID-19 & cancer prevention in Texas: Reasons cited for HPV vaccination hesitancy and refusal during the pandemic |
Onyema Chido-Amajuoyi, Mala Pande, Robert Yu, Sanjay Shete |
| 91 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 5276: COVID-19 and breast cancer care in Ireland: A qualitative study to explore the perspective of breast cancer patients on their health and health care |
Charlotte L. Myers, Catherine Waldron, Kathleen Bennett, Caitriona Cahir |
| 92 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 3585: Disparities in cancer treatment delays or discontinuation among cancer patients diagnosed with SARS-CoV-2 infection: An analysis of the U.S. ASCO COVID-19 and cancer registry |
Jessica Yasmine Islam, Cassandra A. Hathaway, Emma Hume, Kea Turner, Julie Hallanger-Johnson, Shelley S. Tworoger, Marlene Camacho-Rivera |
| 93 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 2266: Host genetic susceptibility to COVID-19 and pandemic -associated stressors |
Maria Gonzalez-Pons, Valeria Valentin, Ingrid Montes-Rodriguez, Maria J. Sanchez, Fabiola M. Morales, Ibis R. Vera-Urbina, Valerie Maldonado-Pino, Estefania I. Ayala, Ediel Rodriguez, Hilmaris Centeno-Girona, Belisa Suarez, Leslie Casiano, Ana Sala, Marcia Cruz-Correa |
| 94 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 442: Exploring the impact that COVID-19 had on patient distress in a rural cancer center |
Sierra Silverwood, Kelly Hirko |
| 95 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 444: COVID-IRIS: Immune reconstitution after G-CSF administration for neutropenia during acute COVID-19 infection |
Chloe S. Lalonde, Tony Z. Zhuang, Amalia A. Aldredge, Max W. Adelman, Abeer N. AbouYabis, Morgan L. McLemore, Sara C. Auld |
| 96 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 5275: The short-term impact of COVID-19 on lung cancer screening participation and adherence |
Yannan Lin, William Hsu, Denise R. Aberle, Ashley E. Prosper |
| 97 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 441: The impact of the COVID-19 on the screening of breast and cervical cancer in Korea |
Hyeree Park, Seung Hee Seo, Jong Heon Park, Bhumsuk Keam, Shin Hye Yoo, Aesun Shin |
| 98 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 433: Colorectal and gastric cancer screening rates in Korea during the COVID-19 pandemic |
Seung Hee Seo, Hyeree Park, Jong Heon Park, Bhumsuk Keam, Shin Hye Yoo, Aesun Shin |
| 99 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 434: Development of virtual outreach strategies to supply cancer education and prevention information during the COVID-19 pandemic |
Monica Yellowhair, Desiree Jones, Gabriela Ruiz, Octavio Castanos, Rene D. Herrera, Juan Contreras, David O. Garcia, Jennifer Hatcher |
| 100 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 439: Physical activity among male cancer survivors during the COVID-19 pandemic |
Colleen B. McGrath, Alaina H. Shreves, Konrad Stopsack, Lilian Cheung, Ann Fisher, Sarah Markt, Lorelei A. Mucci |
| 101 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 438: Psychosocial outcomes, sleep, and substance use among male cancer survivors during the COVID-19 pandemic |
Colleen B. McGrath, Alaina H. Shreves, Konrad Stopsack, Lilian Cheung, Ann Fisher, Sarah Markt, Unnur Valdimarsdottir, Lorelei A. Mucci |
| 102 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 440: Diet and supplement use changes among male cancer survivors during the COVID-19 pandemic |
Alaina H. Shreves, Colleen B. McGrath, Konrad Stopsack, Lilian Cheung, Ann Fisher, Edward Giovannucci, Sarah Markt, Eric Rimm, Lorelei Mucci |
| 103 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 2244: Video-based germline testing for individuals with pancreatic ductal adenocarcinoma: Influence of COVID-19 pandemic |
Saumya Kasliwal, Seyda Baydogan, Devon Harrison, Mark Hurd, Maureen Mork, Anirban Maitra, Florencia McAllister |
| 104 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 6231: Predictors of objectively-measured sedentary time during the COVID-19 pandemic among breast cancer survivors participating in a diet and physical activity intervention |
Sidney Donzella, Chongzhi Di, Eileen Rillamas-Sun, Hanjie Shen, Sofia Cobos, Yuhan Huang, Katherine A. Guthrie, Rachel Yung, Nancy E. Davidson, Heather Greenlee |
| 105 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 6178: COVID-19 pandemic and clinicopathologic characteristics of colorectal cancer in Korea: A multicenter, retrospective study |
Yoon Dae Han, Jun Sang Shin, Sung Uk Bae, Woo Ram Kim, Dae Ro Lim, Chang Woo Kim |
| 106 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 1999: The impact of the COVID-19 pandemic on 30-day survival in pediatric cancer patients in low, middle, and high-income countries: an international, observational cohort study |
Muhammed Elhadi, Soham Bandyopadhyay, Noel Peter, Kokila Lakhoo |
| 107 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 5274: Mechanisms of action (MOA) for proxalutamide, an androgen receptor (AR) antagonist, for the treatment of mild, moderate and severe COVID-19 patients |
Liandong Ma, Youzhi Tong, Qianxiang Zhou, Hongha Yan, Xiaodan Hou, Zhiha Ren, Jiangwei Li, Huiyuan Wang, Weidong Qian, Yu Zhang, Andy Goren, Arul Chinnaiyan |
| 108 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 3587: Racial disparity in COVID-19 severity after adjusting for chronic illnesses and sociodemographic factors |
Xiao-Cheng Wu, Yong Yi, Lauren S. Maniscalco, Mei-Chin Hsieh, DeAnn Gruber, Lee Mendoza, Theresa Sokol, Eileen T. Mederos, Augusto Ochoa |
| 109 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 3586: Immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CART cell therapy |
Thierry Iraguha, Saurabh Dahiya, Stephanie Avila, Aaron Rapoport, Tim Luetkens, Djordje Atanackovic |
| 110 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 3584: COVID-19 vaccination primary and secondary hesitancy among veterans with cancer in the Arkansas-Louisiana-Texas Region |
Philip A. Haddad, Dalia Hammoud, Miriam L. Mcgowen, Laura Houston, Monica Craig, Trenesia McCain, Paige McGovern, Michelle Phelan, Kevin M. Gallagher |
| 111 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract CT258: Interim safety and immunogenicity results of a phase I trial evaluating the multi-peptide COVID-19 vaccine candidate CoVac-1 for induction of SARS-CoV-2 T cell immunity in cancer patients with disease- or treatment-related immunoglobulin deficiency |
Claudia Tandler, Jonas S. Heitmann, Maddalena Marconato, Yacine Maringer, Monika Denk, Marion Richter, Annika Nelde, Imma Fischer, Markus W. Löffler, Hans-Georg Rammensee, Helmut R. Salih, Juliane S. Walz |
| 112 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract CT567: Comprehensive measures of COVID-19 vaccine efficacy in adolescent cancer patients: Results from SerOzNET |
Eva Segelov, Amy Body, Stuart Turville, Corey Smith, Katie Lineburg, Sudha Rao, Robert McCuaig, Stephen Opat, Zin Niang, Luxi Lal, Vi Luong, Hesham Abdulla, Veronica Aedo Lopez, Bhavna Padhye, Noemi Fuentes Bolanos, Antoinette Anazodo, Raina MacIntyre, Peter Downie, Tracey O'Brien, Elizabeth Ahern |
| 113 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 5279: Prognostic serum biomarkers in cancer patients with COVID-19: A systematic review |
Yun-Ju Lai, Te-An Lee, Shih-Han Wang, Chia-Wei Li, Louise D. McCullough, Dhimiter Bello |
| 114 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 5273: The peripheral proinflammatory responses in COVID-19: Clinical spectrum and outcome in patients with and without cancer |
Amer N. Radwi, Zahra H. Alshardi, Rakan H. Alelyani, Raha M. Garout, Lojain N. Alruwaili, Muhammad T. Bakhsh |
| 115 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 446: Outcome of cancer patients with COVID-19: the VCU experience |
Patrick J. Willard, Temmy Olasehinde, Naji Bou Zeid, Edem Defor, Victor Yazbeck, Dipankar Bandyopadhyay |
| 116 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 2056: PI3Kgamma inhibition reduces inflammation and promotes survival in cancer and SARS-CoV-2 |
Judith A. Varner, Anghesom Ghebremedhin |
| 117 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract LB226: Requirement for booster doses in healthy, cancer and immunosuppressed patients infected with the ancestral or variant SARS-CoV-2 |
Chrysovalantis Voutouri, C. Corey Hardin, Vivek Naranbhai, Melin J. Khandekar, Justin F Gainor, Triantafyllos Stylianopoulos, Lance L. Munn, Rakesh K. Jain |
| 118 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 2937: Mutational analysis of ORF-8 of SARS-CoV-2 - a window to immunotherapy |
Gopika Trieu, Nikita Mehta, Jeffrey Park, Andrew Ionescu, Lily Asgari, Vuong Trieu |
| 119 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 5272: Aberrant DNA 5mC and 6mA methylations increase ACE2 expression in intestinal cancer cells susceptible to SARS-CoV-2 infection |
Heng Wang, Yumo Xie, Gaopo Xu, Xiaolin Wang, Meijin Huang, Yanxin Luo, Huichuan Yu |
| 120 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 4249: Quantitative PBMC ADCC bioassay and ADCC reporter bioassays for immunotherapy and SARS-CoV-2 monoclonal antibody development |
Pete Stecha, Jun Wang, Denise Garvin, Julia Gilden, Jamison Grailer, Jim Hartnett, Frank Fan, Mei Cong, Zhi-jie Jey Cheng |
| 121 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 437: Characterization of SARS-CoV-2 using the Ion AmpliSeq SARS-CoV-2 research panel |
Desiree Unselt, Katherine Knudsen, Christopher Rounds, Janet Doolittle-Hall, Fernando Torres, Jennifer Sims, Jennifer Mason |
| 122 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 5277: Humoral SARS-CoV-2 response in asymptomatic precursor plasma cell dyscrasia patients: IMPACT study results |
Yoshinobu Konishi, Romanos Sklavenitis-Pistofidis, Hong Yue, Federico Ferrari, Massimiliano Russo, Robert A. Redd, Jacqueline Perry, Erica Horowitz, Anna V. Justis, Nader A. Shayegh, Elizabeth D. Lightbody, Shohreh Varmeh, Radoslaw P. Nowak, Mark Hamilton, Daniel Auclair, Catherine R. Marinac, Lorenzo Trippa, Eric S. Fischer, Irene M. Ghobrial |
| 123 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract CT259: Comprehensive humoral and cellular immune assessments to SARS-CoV-2 (wild type, delta and omicron) following two- and three-dose vaccination schedule in a large adult cancer population: SerOzNET study: placeholder abstract |
Eva Segelov, Amy Body, Vi Luong, Veronica Aedo Lopez, Luxi Lal, Hesham Abdulla, Stuart Turville, Zin Niang, Stephen Opat, Robert McCuaig, Katie Lineburg, Sudha Rao, Corey Smith, Raina MacIntyre, Elizabeth Ahern |
| 124 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 436: Rapid flow cytometric whole blood assay for assessment of SARS-CoV-2-reactive T cell immunity |
Lorenz Fülle, Philipp David Gert, Verena Traska, Sofia Chatzopoulou, Christian Dose, Anne Richter, Marc Schuster |
| 125 |
[GO] |
Cancer Research |
2022―Jun―15 |
Abstract 3582: Single-cell RNA-sequencing for immune profiling of SARS-CoV2 vaccine response in healthy individuals and patients with precursor plasma cell malignancies |
Romanos Sklavenitis-Pistofidis, Yoshinobu Konishi, Michelle Aranha, Mahshid Rahmat, Ting Wu, Michael Timonian, Shohreh Varmeh, Daniel Heilpern-Mallory, Michael P. Agius, Nang K. Su, Elizabeth D. Lightbody, Jacqueline Perry, Erica M. Horowitz, Anna V. Justis, Daniel Auclair, Catherine R. Marinac, Eric S. Fischer, Gad Getz, Irene M. Ghobrial |
| 126 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―May―04 |
Impact of Exercise on Susceptibility and Severity of COVID-19 in Patients with Cancer: A Retrospective Study |
Joshua W. Bliss, Jessica A. Lavery, Whitney P. Underwood, Su S. Chun, Gina A. Fickera, Catherine P. Lee, Stacie Corcoran, Molly A. Maloy, Fernanda C. Polubriaginof, Daniel W. Kelly, Jessica M. Scott, Paul C. Boutros, Chaya S. Moskowitz, Lee W. Jones |
| 127 |
[GO] |
Cancer Prevention Research |
2022―May―03 |
Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs |
Goli Samimi, Margaret House, Kelly Benante, Lisa Bengtson, Troy Budd, Bridget Dermody, Katina DeShong, Valerie Dyer, Bruce F. Kimler, Vikrant V. Sahasrabuddhe, Suzanne Siminski, Leslie G. Ford, Eduardo Vilar, Eva Szabo |
| 128 |
[GO] |
Cancer Discovery |
2022―May―02 |
Top COVID-19 Prognostic Factors Identified |
|
| 129 |
[GO] |
Cancer Discovery |
2022―Apr―04 |
Vive la Résistance: T-cell Immunity in the Protection against SARS-CoV-2 Infection |
Lisa H.F. McGary, Santosha A. Vardhana |
| 130 |
[GO] |
Blood Cancer Discovery |
2022―Mar―09 |
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a CCC19 registry analysis |
Samuel M. Rubinstein, Divaya Bhutani, Ryan C. Lynch, Chih-Yuan Hsu, Yu Shyr, Shailesh Advani, Ruben A. Mesa, Sanjay Mishra, Daniel P. Mundt, Dimpy P. Shah, R. Alejandro Sica, Keith E. Stockerl-Goldstein, Catherine Stratton, Matthias Weiss, Alicia Beeghly-Fadiel, Melissa Accordino, Sarit E. Assouline, Joy Awosika, Ziad Bakouny, Babar Bashir, Stephanie Berg, Mehmet Asim. Bilen, Cecilia A. Castellano, Jacob C. Cogan, Devendra KC, Christopher R. Friese, Shilpa Gupta, Daniel Hausrath, Clara Hwang, Nathalie A. Johnson, Monika Joshi, Anup Kasi, Elizabeth J. Klein, Vadim S. Koshkin, Nicole M. Kuderer, Daniel H. Kwon, Chris Labaki, Tahir Latif, Eric Lau, Xuanyi Li, Gary H. Lyman, Rana R. McKay, Gayathri Nagaraj, Amanda Nizam, Taylor K. Nonato, Adam J. Olszewski, Hyma V. Polimera, Andrew J. Portuguese, Matthew M. Puc, Pedram Razavi, Rachel Rosovski, Andrew Schmidt, Sumit A. Shah, Aditi Shastri, Christopher Su, Pallawi Torka, Trisha M. Wise-Draper, Leyre Zubiri, Jeremy L. Warner, Michael A. Thompson |
| 131 |
[GO] |
Cancer Discovery |
2022―Mar―09 |
The polarity and specificity of antiviral T lymphocyte responses determine susceptibility to SARS-CoV-2 infection in cancer patients and healthy individuals. |
Jean-Eudes Fahrner, Imran Lahmar, Anne-Gaelle Goubet, Yacine Haddad, Agathe Carrier, Marine Mazzenga, Damien Drubay, Carolina Alves Costa Silva, Lyon Covid Study Group, Eric de Sousa, Cassandra Thelemaque, Clea Melenotte, Agathe Dubuisson, Arthur Geraud, Gladys Ferrere, Roxanne Birebent, Camille Bigenwald, Marion Picard, Luigi Cerbone, Joana R. Lerias, Ariane Laparra, Alice Bernard-Tessier, Benoit Kloeckner, Marianne Gazzano, Francois-Xavier Danlos, Safae Terrisse, Eugenie Pizzato, Caroline Flament, Pierre Ly, Eric Tartour, Nadine Benhamouda, Lydia Meziani, Abdelhakim Ahmed-Belkacem, Makoto Miyara, Guy Gorochov, Fabrice Barlesi, Alexandre Trubert, Benjamin Ungar, Yeriel Estrada, Caroline Pradon, Emmanuelle Gallois, Fanny Pommeret, Emeline Colomba, Pernelle Lavaud, Marc Deloger, Nathalie Droin, Eric Deutsch, Bertrand Gachot, Jean-Philippe Spano, Mansouria Merad, Florian Scotte, Aurelien Marabelle, Frank Griscelli, Jean-Yves Blay, Jean-Charles Soria, Miriam Merad, Fabrice Andre, Juliette Villemonteix, Mathieu F. Chevalier, Sophie Caillat-Zucman, Florence Fenollar, Emma Guttman-Yassky, Odile Launay, Guido Kroemer, Bernard La Scola, Markus Maeurer, Lisa Derosa, Laurence Zitvogel |
| 132 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P4-12-09: Implications of protocol modifications and treatment delays for breast cancer patient experiences during Covid-19 |
Tamara Hamlish, Elizabeth L Papautsky |
| 133 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-01-12: The impact of COVID-19 on diagnosis of recurrent breast cancer |
Serena Di Cosimo, Catherine Depretto, Rosalba Miceli, Paolo Baili, Silva Ljevar, Milena Sant, Claudio Ferranti, Secondo Folli, Massimiliano Gennaro, Filippo G de Braud, Claudio Vernieri, Maria Carmen De Santis, Laura Lozza, Andrea Vingiani, Giancarlo Pruneri, Giovanni Apolone, Alfonso Marchianò, Gianfranco P Scaperrotta |
| 134 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P2-11-08: Impact of COVID-19 on patients undergoing neoadjuvant therapy: A pre/post pandemic analysis and assessment of quality of care delivered |
Lauren Corke, Omar Hajjaj, Kaylie Willemsma, Stephen Chia, Christine Simmons |
| 135 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P2-10-05: The estimated impact of COVID-19 on population breast cancer screening outcomes, and options for risk-based recovery |
Pietro Procopio, Sabine Deij, Louiza S Velentzis, Amanda Tattam, Lara Petelin, Carolyn Nickson |
| 136 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P1-17-07: Consequences of stopping a 4/6 cyclin D-dependent kinase Inhibitor in metastatic breast cancer patients with clinical benefit on endocrine treatment, in the context of the COVID-19 outbreak |
Sophie Martin, Carole Pflumio, Philippe Trensz, Frederique Schaff-Wendling, Michal Kalish, Cathie Fischbach, Laure Pierard, Jean-Marc Limacher, Michel Velten, Thierry Petit |
| 137 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-12-37: The impact of the COVID-19 outbreak on breast cancer stage in the Netherlands by screening status |
Anouk H Eijkelboom, Sabine Siesling, Linda de Munck, Carla H van Gils, Marc BI Lobbes, Vivianne CG Tjan-Heijnen, Luc JA Strobbe, Jelle Wesseling, Ruud M Pijnappel, Mireille JM Broeders |
| 138 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-12-09: Impact of the COVID-19 outbreak on the treatment strategy of Dutch breast cancer patients |
Anouk H Eijkelboom, Sabine Siesling, Linda de Munck, Desiree HJG van den Bongard, Willemien Menke-van der Houven van Oordt, Pieter J Westenend, Ester JM Siemerink, Luc JA Strobbe, Marie-Jeanne TFD Vrancken Peeters, Linetta B Koppert, Marc AM Mureau, Agnes Jager, Mireille JM Broeders, Marc BI Lobbes, Helena M Verkooijen, Jelle Wesseling, Marjolein Smidt, Vivianne CG Tjan-Heijnen |
| 139 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P5-14-06: Predictors of adherence to oral endocrine therapy in racial and ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic |
Sama Rahimi, Onyebuchi Ononogbu, Anjana Mohan, Daniel Moussa, Susan Abughosh, Meghana V Trivedi |
| 140 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P5-14-03: National claims data analysis of breast cancer diagnosis and treatment before versus during the COVID-19 pandemic |
Jennifer L Caswell-Jin, Maryam N Shafaee, Lan Xiao, Mina Liu, Natasha Purington, Esther M John, Melissa L Bondy, Allison W Kurian |
| 141 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P5-14-15: Examining inequities related to inpatient hospital length of stay for breast cancer patients: A retrospective study during the COVID-19 pandemic |
Sailaja Kamaraju, Bethany Canales, Tamiah Wright, John Charlson, Aniko Szabo, Thomas Wetzel, Steve Power, Grace Campbell |
| 142 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P5-14-01: National claims data analysis of breast cancer diagnosis and treatment before versus during the COVID-19 pandemic |
Jennifer L Caswell-Jin, Maryam N Shafaee, Lan Xiao, Mina Liu, Natasha Purington, Esther M John, Melissa L Bondy, Allison W Kurian |
| 143 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P2-13-17: A phase III, randomized, multicenter, double-blind study to compare efficacy and safety of EG12014 (EirGenix trastuzumab) with Herceptin® as neoadjuvant treatment in combination with anthracycline/paclitaxel-based systemic therapy in patients with HER2-positive early breast cancer - a multinational phase III study conducted during the COVID-19 pandemic |
Barbara Grohmann-Izay, Chiun-Sheng Huang, Giorgi Dzagnidze, Nestor Llinas, Anand Misra, Denys Pominchuk, Alexander Prokhorov, Bernardo Rapoport, Vladimir Semiglazov, Ling-Ming Tseng, Eduardo Yanez Ruiz, Sibylle Loibl |
| 144 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-04-04: Multi-institutional perspective on screening mammography and breast cancer stage at diagnosis during the COVID-19 pandemic |
Sarah J Stephens, Maxwell R Lloyd, Julian C Hong, Tejas Mehta, Ted A James, Rachel Blitzblau, Abram Recht, Daphna Y Spiegel |
| 145 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-23-04: A comprehensive, multidisciplinary approach to breast cancer treatment during the COVID-19 pandemic improves time to treatment |
Amila Orucevic, Robin Hutson, Robert Heidel, Jillian Lloyd, Garnetta Morin-Ducote, Christine Lauro, Ellen Perkins, Timothy Panella, Lisa Duncan, Stuart VanMeter, John Bell |
| 146 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P4-12-12: Assessing the impact of the COVID-19 pandemic on cancer treatment decision-making and care experiences |
Noura Alsafar, Desiree Hao, Nimira Alimohamed, Sunil Samnani, Sasha Lupichuk |
| 147 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-09-19: The utility of using genomic testing on needle core biopsies during the COVID-19 pandemic: Molecular characterization, risk stratification, neoadjuvant outcome, and future implications |
Hani Katerji, Huina Zhang, Xi Wang, Linda Schiffhauer, Ajay Dhakal, Alissa Huston, Carla Falkson, David Hicks, Bradley Turner |
| 148 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-03-19: Incidence and time to resolution of axillary adenopathy on mammography after COVID-19 vaccination |
Kristin Robinson, Santo Maimone, Pooja P Advani, Zhuo Li, Denise Gococo-Benore, Neda Qosja, Ashita Mummareddy, Ahmed M Ashai, Annamaria Wilhelm, Robert Maxwell, Martha Wasserman, Neema Patel, Andrey Morozov, Saranya Chumsri |
| 149 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P1-01-01: Prospective ultrasonographic surveillance study for incidence and recovery period of COVID-19 vaccination-related axillary lymphadenopathy |
Kumiko Kida, Hiroko Tsunoda, Risa Kasahara, Chika Tsutsumi, Akiko Numata, Yuri Takehara, Atsushi Yoshida, Junko Takei, Naoki Hayashi, Daiki Kobayashi, Hideko Yamauchi |
| 150 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P5-14-17: Declining the COVID-19 vaccination: An evaluation of why some high risk cancer patients decline vaccination |
Kate I Lathrop, Eva Prieto, Stefany Viveros, Salyna Riggs, Eva Balboa, Juanita Murray, Cynthia Evans, Sukeshi Arora |
| 151 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P2-15-03: Neoadjuvant endocrine therapy (NET) as bridge therapy for early stage breast cancer during COVID-19: A single institution experience |
Julie Huang, Joshua Feinberg, Bahram Dabiri, Jordan Baum, Meredith Akerman, Anthony Pasquarella, Abhinav Rohatgi, Shubhada Dhage, Amber Guth, Nina D'Abreo |
| 152 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P2-03-01: Changes in breast cancer presentation during Covid-19: Experience in an Urban Academic Center |
Amber Azniv Guth, Brian Diskin, Freya Schnabel, Nakisa Pourkey, Deborah Axelrod, Richard Shapiro |
| 153 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P5-14-20: Neoadjuvant endocrine therapy (NET) during COVID-19: Single institution survey of patients’ perspectives |
Julie Huang, Joshua Feinberg, Meredith Akerman, Anthony Pasquarella, Abhinav Rohatgi, Bahram Dabiri, Jordan Baum, Shubhada Dhage, Amber Guth, Nina D'Abreo |
| 154 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-23-01: Antibody responses after SARS-CoV-2 mRNA vaccination in breast cancer patients |
Saranya Chumsri, Pooja P. Advani, Tanmayi S Pai, Zhou Li, Marites Acampora, Gina A Reynolds, Alvaro Moreno-Aspitia, Christopher P Marquez, Keith L. Knutson |
| 155 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P4-10-03: Immunogenicity of SARS-CoV-2 vaccination in subjects on active treatment for breast cancer |
Cory Bivona, Kevin Li, Priyanka Sharma, Jianghua He, Grace Martin, Andrew K Godwin, Anthony Rooney, Stephen Williamson, Gary Doolittle, Weijing Sun, Bruce F Kimler, Anne P O'Dea, Lauren E Nye, Joseph P McGuirk, Ziyan Pessetto, Lisa Haney, Nicole Balmaceda, Laura Mitchell, Karissa Finke, Maggie Nelson, Dinesh Pal Mudaranthakam, Natalie Streeter, Stephanie Lafaver, Jaimie Heldstab, Qamar J Khan |
| 156 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-23-02: Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer receiving CDK 4/6 inhibitors |
Elyssa Denault, Erika Nakajima, Vivek Naranbhai, Alejandro Balazs, Lindsey Mortensen, Elizabeth Niehoff, Caroline Barabell, Jennifer A. Hutchinson, Seth A. Wander, Aron S. Rosenstock, Leif W. Ellisen, Beverly Moy, Steven J. Isakoff, Justin F. Gainor, A. John Iafrate, Aditya Bardia, Laura M. Spring |
| 157 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-11-02: Evaluation of the effects of anticancer treatments in cancer patients undergoing SARS-COV2 vaccination (VAX-on study: Breast cancer subgroup analysis) |
Agnese Fabbri, Eleonora Marrucci, Fabrizio Nelli, Marco Mazzotta, Angelo Onorato, Primi Francesca, Mario Giovanni Chilelli, Antonella Virtuoso, Carlo Signorelli, Julio R Giron Berrios, Marta Schirripa, Rossella Donghia, Enzo Maria Ruggeri |
| 158 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P4-10-06: Best quality care from a distance (BQual-D): Maintaining high quality care for hormone receptor positive (HR+) metastatic breast cancer (MBC) during the COVID pandemic, description of the program and provider satisfaction |
Gretchen Kimmick, Smrithi Davakaran, Heather Moore, Cynthia Rose, Pamela Gentry, Michael Willis, Susan Dent, Sarah Sammons, Jeremy Force, Kelly Westbrook, Carey Anders, Rebecca Shelby |
| 159 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P4-12-13: Psychosocial aspects in relation to clinical status of breast cancer patients after prolonged COVID pandemic in south India: A observational survey study |
Chandralekha Krishnan |
| 160 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P5-14-04: Changes in management of TNBC during the COVID19 pandemic of 2020 |
Dave Smart, Wendy L Allen, Raymond H Henderson, Susanne Munksted, Peter Riccelli |
| 161 |
[GO] |
Cancer Research |
2022―Mar―08 |
Abstract P3-17-06: Telephone triaging during the 1st wave of the COVID 19 Pandemic: Outcomes and proposed pathway for managing patients referred for breast pain |
Urvashi Jain, Robyn Coombe, Georgina Bitsakou, Ashutosh Kothari |
| 162 |
[GO] |
Clinical Cancer Research |
2022―Feb―09 |
AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care |
Patrick A. Williams, Sayyed Kaleem Zaidi, Rajarshi Sengupta |
| 163 |
[GO] |
Cancer Immunology Research |
2022―Jan―24 |
Immune-guided therapy of COVID-19 |
Gianfranco Ferraccioli, Elisa Gremese, Delia Goletti, Linda Petrone, Fabrizio Cantini, Stefano Ugel, Stefania Canè, Vincenzo Bronte |
| 164 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Jan―11 |
Abstract PO-108: Predictors of retention rates in the Active Living After Cancer program at MD Anderson Cancer Center: A comparison of classes during and before COVID-19 |
Kendahl Servino, Stacy Mitchell, Che Young Lee, Yue Liao, Karen Basen-Engquist |
| 165 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Jan―11 |
Abstract PO-056: The ReTOOL training program for underrepresented minority students: Best practices for virtual training in midst of COVID-19 |
Parisa Fathi, Folakemi Odedina, John Allen, Debra Lyon, Diana Wilkie, Nissa Askins, Brian Seymour |
| 166 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Jan―11 |
Abstract PO-017: The association of COVID-19 and cancer screening inquiries among Spanish speakers: An examination of NCI Cancer Information Service data |
Heather N. Platter, Adaora Ezeani, Travis Hyams, Grace C. Huang, Robin C. Vanderpool, William M.P. Klein |
| 167 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Jan―11 |
Abstract PO-075: COVID-19 and social determinants of health (SDOH): Impact on cancer prevention in GENZ population (Ages 18-25) |
Beth A. Jones, Sakinah C. Suttiratana, Shua Kim, William Eger |
| 168 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Jan―11 |
Abstract PO-125: Mental health symptoms during the COVID-19 pandemic among cancer survivors who endorse cannabis: Results from the COVID-19 cannabis health study |
Diane L. Rodriguez, Denise C. Vidot, Marlene Camacho-Rivera, Jessica Y. Islam |
| 169 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Jan―11 |
Abstract PO-115: Defining radiation treatment quality disparities in the COVID-19 Era |
Elizabeth C. Gaudio, Nariman Ammar, Daniel V Wakefield, Maria Pisu, Arash Shaban-Nejad, David L Schwartz |
| 170 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Jan―11 |
Abstract PO-122: Palliative care for 317 cancer patients with COVID-19 in a major public hospital in South America |
Tulio L. Correa, Joyce V.B. Sobreira, Áurea M.S. Simão, Fernanda B. Anbar, Flavia Yarshell, Ricardo T. de Carvalho |
| 171 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Jan―11 |
Abstract PO-041: The impact of COVID-19 on cancer care in the Latinx community in Northern California: A mixed method community-engaged research study |
Patricia Rodriguez Espinosa, Darcie Green, Yessica Martinez Mulet, Miriam L. Trigo, Natalia M. Zamora Zeledon, Eric Meléndez, Lisa G. Rosas |
| 172 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Jan―11 |
Abstract PO-253: Overcoming barriers to colorectal cancer screening for underserved patients: Lessons from the COVID-19 pandemic |
Kathryn M. Glaser, Christina Crabtree-Ide, Alyssa McNulty, Ellis Gomez, Nicole Donofrio, Tessa Flores, Mary E. Reid |
| 173 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Jan―11 |
Abstract PO-081: Cancer clinical trial access during the COVID-19 pandemic |
Ashithkumar Beloor Suresh, Subecha Dahal, Christopher Gantz, AnaMaria Lopez |
| 174 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Jan―11 |
Abstract PO-027: A Puerto Rico free of preventable diseases: An online education intervention for school staff during the COVID-19 pandemic era in Puerto Rico |
Diana T. Medina-Laabes, VOCES PR Coalition, JAC-HPV PIVAC PR, Omayra Salgado Cruz, Roxana Soto Abreu, Olga L. Diaz Miranda, Marta M. Sánchez Aracil, Vivian Colón-López |
| 175 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Jan―11 |
Abstract PO-065: Increasing breast and cervical cancer knowledge during COVID-19 pandemic in collaboration with Cooperative Extension Program |
Omayra Salgado, Ircha Martinez, Nelybeth Santiago, Mirza Rivera, Taina De La Torre, Guillermo Tortolero |
| 176 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Jan―11 |
Abstract PO-093: The impact of the COVID-19 pandemic on care delivery and quality of life in lung cancer surgery |
Dede K. Teteh, Betty Ferrell, Xiaoke Zou, Loretta Erhunmwunsee, Dan Raz, Jae Kim, Virginia Sun |
| 177 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Jan―11 |
Abstract PO-238: Implementing a culturally-appropriate biospecimen collection protocol during the COVID-19 pandemic to address cervical cancer disparities among Native American women |
Skyler Bordeaux, Elisa Martinez, Pawel Laniewski, Natalie Metz, Verity Quioz, Donna Peace, Gregory Caporaso, Melissa Herbst-Kralovetz, Naomi Lee |
| 178 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Jan―11 |
Abstract PO-252: Impact of COVID-19 public policies on utilization on cervical cancer screening in Puerto Rico during March 15, 2020 to July 31, 2020 |
Axel Gierbolini-Bermúdez, Karen Ortiz-Ortiz, Jeslie M Ramos- Cartagena, Kalyani Sonawane, Vivian Colón-Lopez, Ashish Deshmukh, Ana P Ortiz |
| 179 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Jan―11 |
Abstract PO-250: Impact of age, race, and family history on COVID-19 related changes in breast cancer screening among the Boston Mammography Cohort Study |
Naiyu Chen, David Cheng, Mollie Barnard, Natalie C. DuPre, Rulla M. Tamimi, Erica T. Warner |
| 180 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Jan―11 |
Abstract PO-158: Influence of health beliefs on COVID-19 vaccination among patients with cancer and other comorbidities in Puerto Rico |
McClaren Rodriguez, Andrea López-Cepero, Ana Patricia Ortiz, Emma Fernández-Repollet, Cynthia Pérez |
| 181 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2022―Jan―11 |
Abstract PO-029: Community coalition and academic need assessment: Our first step for the development of an educational intervention on HPV vaccination targeting school staff during pandemic era in Puerto Rico |
Josheili S. Llavona, Diana T. Medina Laabes, Omayra Salgado Cruz, JAC-HPV-PIVac PR, Roxana Soto Abreu, Olga L. Diaz Miranda, Marta M. Sánchez Aracil, Vivian Colón-López |
| 182 |
[GO] |
Cancer Immunology Research |
2022―Jan―04 |
Abstract IA07: Impact of immunotherapy on COVID-19 immunity: Insights from checkpoint blockade in cancer |
Paulina Coutifaris, Kevin Wang, Sokratis Apostolidis, Mark Painter, Ahron Flowers, Rishi Goel, Divij Mathew, Ajinkya Pattekar, Ravi Amaravadi, Tara Mitchell, Paul Bates, Scott Hensley, Giorgos Karakousis, Lynn Schuchter, Allie Greenplate, E. John Wherry, Alexander C. Huang |
| 183 |
[GO] |
Cancer Immunology Research |
2022―Jan―04 |
Abstract IA08: Adaptive immune dysregulation in cancer patients with SARS-CoV-2 infection |
Santosha A. Vardhana |
| 184 |
[GO] |
Cancer Immunology Research |
2022―Jan―04 |
Abstract P006: Intratumoral electroporation of IL-12 and SARS-Cov-2 spike plasmids drives a coordinated vaccine response and elicits robust anti-tumor immunity |
Mia Han, Jack Y. Lee, Vincent Wu, Kurt Sakurada, Bianca Nguyen, David A. Canton, Christopher G. Twitty |
| 185 |
[GO] |
Cancer Discovery |
2021―Dec―22 |
Pandemic Provides Rapid Test of Telehealth |
|
| 186 |
[GO] |
Cancer Discovery |
2021―Dec―10 |
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer |
Arielle Elkrief, Julie T Wu, Chinmay Jani, Kyle T Enriquez, Michael Glover, Mansi R Shah, Hira Ghazal Shaikh, Alicia Beeghly-Fadiel, Benjamin French, Sachin R Jhawar, Douglas B. Johnson, Rana R McKay, Donna R Rivera, Daniel Y Reuben, Surbhi Shah, Stacey L Tinianov, Donald Cuong Vinh, Sanjay Mishra, Jeremy L Warner |
| 187 |
[GO] |
Cancer Discovery |
2021―Dec―09 |
Navigating Cancer Care in the COVID-19 Era |
|
| 188 |
[GO] |
Molecular Cancer Therapeutics |
2021―Dec―03 |
Abstract P161: Impaired serological response to SARS-CoV-2 mRNA vaccination in patients with hematologic malignancies |
Lee M. Greenberger, Larry A. Saltzman, Jonathon W. Senefeld, Patrick W. Johnson, Louis J. DeGennaro, Gwen L. Nichols |
| 189 |
[GO] |
Cancer Research |
2021―Nov―10 |
Longitudinal SARS-CoV-2 mRNA vaccine-induced humoral immune responses in cancer patients |
Jane C Figueiredo, Noah M Merin, Omid Hamid, So Yung Choi, Tucker Lemos, Wendy Cozen, Nathalie Nguyen, Laurel J Finster, Joslyn Foley, Justin Darrah, Jun Gong, Ronald Paquette, Alain C Mita, Robert Vescio, Inderjit Mehmi, Reva Basho, Warren G Tourtellotte, Carissa A Huynh, Gil Y Melmed, Jonathan Braun, Dermot PB McGovern, Emebet Mengesha, Greg Botwin, John C Prostko, Edwin C Frias, James L Stewart, Sandy Joung, Jennifer Van Eyk, Joseph E Ebinger, Susan Cheng, Kimia Sobhani, Karen L Reckamp, Akil Merchant |
| 190 |
[GO] |
Cancer Discovery |
2021―Nov―09 |
Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies |
Christina Y. Lee, Monika K Shah, David Hoyos, Alexander Solovyov, Melanie Douglas, Ying Taur, Peter Maslak, N Esther Babady, Benjamin Greenbaum, Mini Kamboj, Santosha A Vardhana |
| 191 |
[GO] |
Cancer Discovery |
2021―Oct―06 |
COVID-19 Use Causes Tocilizumab Shortage |
|
| 192 |
[GO] |
Cancer Prevention Research |
2021―Oct―04 |
Rethinking Cervical Cancer Screening in Brazil Post COVID-19: A Global Opportunity to Adopt Higher Impact Strategies |
Ana Ribeiro, Flávia Corrêa, Arn Migowski, Aline Leal, Sandro Martins, Tainá Raiol, Carla P. Marques, Katia L. Torres, Akiva P. Novetsky, Jenna Z. Marcus, Nicolas Wentzensen, Mark Schiffman, Ana Cecilia Rodriguez, Julia C. Gage |
| 193 |
[GO] |
Clinical Cancer Research |
2021―Sep―28 |
Immunogenicity and safety of COVID-19 vaccine BNT162b2 for patients with solid cancer: a large cohort prospective study from a single institution. |
Vincenzo Di Noia, Fulvia Pimpinelli, Davide Renna, Vittoria Barberi, Maria Teresa Maccallini, Ludovica Gariazzo, Martina Pontone, Alessandro Monti, Flaminia Campo, Emanuela Taraborelli, Maria Di Santo, Fabrizio Petrone, Chiara Mandoj, Virginia Ferraresi, Gianluigi Ferretti, Paolo Carlini, Ornella Di Bella, Laura Conti, Antonia Marina La Malfa, Raul Pellini, Domenico Bracco, Diana Giannarelli, Aldo Morrone, Francesco Cognetti |
| 194 |
[GO] |
Blood Cancer Discovery |
2021―Sep―15 |
How to provide the needed protection from COVID-19 to patients with hematologic malignancies |
Antoni Ribas, Madhav V Dhodapkar, Katie M Campbell, Faith E Davies, Steven D. Gore, Ronald Levy, Lee M Greenberger |
| 195 |
[GO] |
Blood Cancer Discovery |
2021―Sep―13 |
Disease and therapy-specific impact on humoral immune responses to COVID-19 vaccination in hematologic malignancies |
David J Chung, Gunjan L. Shah, Sean M. Devlin, Lakshmi V Ramanathan, Sital Doddi, Melissa S Pessin, Elizabeth Hoover, LeeAnn T Marcello, Jennifer C Young, Sawsan R Boutemine, Edith Serrano, Saumya Sharan, Saddia Momotaj, Lauren Margetich, Christina D Bravo, Genovefa A Papanicolaou, Mini Kamboj, Anthony R. Mato, Lindsey E. Roeker, Malin Hultcrantz, Sham Mailankody, Alexander M Lesokhin, Santosha A Vardhana, David A Knorr |
| 196 |
[GO] |
Blood Cancer Discovery |
2021―Sep―13 |
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T Cell Therapy |
Roni Tamari, Ioannis Politikos, David A Knorr, Santosha A Vardhana, Jennifer C Young, LeeAnn T Marcello, Sital Doddi, Sean M. Devlin, Lakshmi V Ramanathan, Melissa S Pessin, Erica Dunn, Meighan Palazzo, Christina D Bravo, Genovefa A Papanicolaou, Mini Kamboj, Miguel-Angel Perales, David J Chung, Gunjan L. Shah |
| 197 |
[GO] |
Cancer Discovery |
2021―Sep―01 |
Impaired CD4 T-cell Response to SARS-CoV-2: Rationale for PD-1 Blockade in Patients with Cancer and COVID-19? |
Bérengère Salomé, Amir Horowitz |
| 198 |
[GO] |
Cancer Discovery |
2021―Jul―21 |
Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective |
Keith T. Flaherty, James H. Doroshow, Susan Galbraith, Antoni Ribas, Paul G. Kluetz, Richard Pazdur, Marc R. Theoret |
| 199 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Jul―16 |
Characteristics and outcomes of over 300,000 COVID-19 individuals with history of cancer in the United States and Spain |
Elena Roel, Andrea Pistillo, Martina Recalde, Anthony G Sena, Sergio Fernandez-Bertolin, Maria Aragon, Diana Puente, Waheed-Ul-Rahman Ahmed, Heba Alghoul, Osaid Alser, Thamir M. Alshammari, Carlos Areia, Clair Blacketer, William Carter, Paula Casajust, Aedín C. Culhane, Dalia Dawoud, Frank DeFalco, Scott L DuVall, Thomas Falconer, Asieh Golozar, Mengchun Gong, Laura Hester, George Hripcsak, Eng Hooi Tan, Hokyun Jeon, Jitendra Jonnagaddala, Lana YH Lai, Kristine E Lynch, Michael E Matheny, Daniel R Morales, Karthik Natarajan, Fredrik Nyberg, Anna Ostropolets, Jose D Posada, Albert Prats-Uribe, Christian G Reich, Donna R Rivera, Lisa M Schilling, Isabelle Soerjomataram, Karishma Shah, Nigam H. Shah, Yang Shen, Matthew Spotnitz, Vignesh Subbian, Marc A Suchard, Annalisa Trama, Lin Zhang, Ying Zhang, Patrick B Ryan, Daniel Prieto-Alhambra, Kristin Kostka, Talita Duarte-Salles |
| 200 |
[GO] |
Cancer Discovery |
2021―Jul―16 |
Patients with Solid Tumors Seroconvert after SARS-CoV-2 mRNA Vaccine |
|
| 201 |
[GO] |
Cancer Discovery |
2021―Jul―07 |
COVID-19 Vaccines Complicate Breast Screening |
|
| 202 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Jul―07 |
Excess mortality in a nationwide cohort of cancer patients during the initial phase of the COVID 19 pandemic in Belgium |
Geert Silversmit, Freija Verdoodt, Nancy Van Damme, Harlinde De Schutter, Liesbet Van Eycken |
| 203 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 703: An inflammatory leptomeningeal signature in cancer patients with neurologic manifestations of COVID-19 |
Jessica A. Wilcox, Jan Remsik, N. Esther Babady, Tracy A. McMillen, Behroze A. Vachha, Neil A. Halpern, Vikram Dhawan, Marc Rosenblum, Christine A. Iacobuzio-Donahue, Edward K. Avila, Bianca Santomasso, Adrienne Boire |
| 204 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 710: Androgen-deprivation therapy boosts MX1 expression, a silent effector against COVID-19 |
Juan Antonio Bizzotto, Pablo Sanchis, Sofia Lage-Vickers, Rosario Lavignolle, Agustina Sabater, Mercedes Abbate, Ayelen Toro, Florencia Cascardo, Santiago Olszevicki, Nicolas Anselmino, Estefania Labanca, Emiliano Ortiz, Elba Vazquez, Javier Cotignola, Geraldine Gueron |
| 205 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 714: From cancer to COVID-19- development of a dendritic cell-targeted nano-vaccine for prevention and therapy of COVID-19 |
Daniella Vaskovich-Koubi, Ron Kleiner, Yulia Liubomirski, Eilam Yeini, Galia Tiram, Sabina Pozzi, Anat Eldar-Boock, Helena F. Florindo, Ronit Satchi-Fainaro |
| 206 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 704: Sex and age differences in telomere length and susceptibility to COVID-19 |
Manar Ahmed Kamal, Kareem Reda Alamiry, Mahmoud Zaki |
| 207 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 711: Repurposing 2nd generation androgen receptor antagonist Proxalutamide to treat COVID-19 |
Liandong Ma, Youzhi Tong, Qiang Guo, Yifeng Zhou, Qianxiang Zhou, Honghua Yan |
| 208 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 709: Estrogen and androgen receptor inhibitors: Unexpected allies in the fight against COVID-19 |
Sara Bravaccini, Eugenio Fonzi, Michela Tebaldi, Davide Angeli, Giovanni Martinelli, Fabio Nicolini, Paola Parrella, Massimiliano Mazza |
| 209 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Jul―01 |
Abstract 74: Stakeholder Selected Strategies to Improve Breast Cancer Care in East Africa: Preliminary Implementation Outcomes and Impact Of COVID-19 |
Anne Rositch, Christina Chao, Matogoro Kirahi, Nestory Masalu, Lucas Faustine, Leonard Washington Amango |
| 210 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 700: CellSig: A data-driven model of cytokine activity identifies therapeutic targets for severe COVID-19 and cancer immunotherapy-induced colitis |
Peng Jiang, Yu Zhang, Beibei Ru, Eytan Ruppin, Kai Wucherpfennig |
| 211 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 722: The hallmark of COVID-19 cancer disparities: Cellular sequelae |
Eva McGhee, Mengtao LI, Yi-Ling Lin, Nefertari Carr, Chinelo Njubigbo, Rohun Sadeghi, Brooke Su-Velez, Julian Handler, Adin Handler, Judith Okoro, Sebhat Afework, Jay Vadgama |
| 212 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract LB076: Association between regional COVID-19 hospitalizations and treatment delays amongst confirmed cancer patients in England, UK |
Louis Fox, Ajay Aggarwal, Richard Sullivan, Kate Haire, Arnie Purushotham, James Spicer, Sophie Papa, Anne Rigg, Saoirse Dolly, Mieke Van Hemelrijck |
| 213 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract LB074: Chymostatin, a cathepsin L inhibitor, inhibits lung cancer cell proliferation and COVID-19 Mpro in vitro |
Nagendra Sastry Yarla, Gopal Pathuri, Simon Terzyan, Yuting Zhang, Anil Singh, Marcus T. Scotti, Venkateshwar Madka, Chinthalapally V. Rao |
| 214 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract CT201: Early report of a phase I/II study of human placental hematopoietic stem cell derived natural killer cells (CYNK-001) for the treatment of adults with COVID-19 (NCT04365101) |
Corey Casper, Leonid Groysman, Vinay Malhotra, Eric Whitman, Stacy Herb, Erica Rave, Alan Lew, Cristina Goman, Zachary Sagawa, Monica Thakar, Victoria Lacasse, Cherie Daly, Shuyang He, Lin Kang, Sharmila Koppisetti, Tanel Mahlakõiv, Sunday Osokoya, William van der Touw, Junhong Zhu, Greg Berk, Xiaokui Zhang, Andrew Pecora, Robert Hariri |
| 215 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract LB073: The growth inhibitory effect of paclitaxel on gefitinib-resistant non-small cell lung cancer (NSCLC) cells during the COVID-19 pandemic |
Md Mohiuddin, Hideharu Kimura, Takashi Sone, Satoshi Watanabe, Hiroki Matsuoka, Keigo Saeki, Nanao Terada, Miki Abo, Kazuo Kasahara |
| 216 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 716: Telehealth use among multiple myeloma patients during the COVID-19 pandemic |
Nathan W. Sweeney, Scott R. Goldsmith, Jennifer M. Ahlstrom |
| 217 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 719: The emergence of the COVID-19 pandemic and its impact on a novel cancer care delivery model at Federally Qualified Health Centers |
Nicolas Francone, Will Dunne, Jonathan Alhalel, Sankirtana Danner, Nihmotallahi Adebayo, T Madorsky, Cassandra Osei, Juan Rivera, J Trossman, Christine Weldon, Elizabeth Adetoro, Melissa Simon |
| 218 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Jul―01 |
Abstract 11: Neglected Elements of Cancer Control During The COVID-19 Pandemic in Africa: Call for Action from 2019-2020 African Cancer Research and Control ECHO Programme |
Annet Nakaganda, Nwamaka Lasebikan, Elise M. Garton, Benda Kithaka, Mishka K. Cira |
| 219 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Jul―01 |
Abstract 31: Impact of the COVID-19 Pandemic on Cancer Registry Operations in the Caribbean |
Sarah Quesnel-Crooks, Rachel Hanisch, Isabelle Soerjomataram, Brenda Edwards, Arica White, Betsy Kohler, Ann Chao, Les Mery, Glennis Andall-Brereton |
| 220 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 717: Rapid transformation of TTFields care-delivery during COVID-19 pandemic to optimize treatment of patients with glioblastoma (GBM) |
Peggy M. Frongillo, Melissa Shackelford, Lindsay Rain |
| 221 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 721: Early death in acute lymphoblastic leukemia during COVID-19 pandemic: A single institution cohort study |
Daniel J. Enriquez-Vera, Ali Al-kassab-Cordova, Lizbeth Lachira-Yparraguirre, Gustavo Sandival-Ampuero, Bryan Valcarcel, Cesar Samanez, Juan Haro-Varas, Shirley Quintana-Truyenque, Luis Malpica, Henry Gomez-Leonidas, Tatiana Vidaurre-Rojas |
| 222 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 1162: Monitoring COVID-19 RNA methyltransferases activities for developing therapeutic drugs |
Said A. Goueli, Kevin Hsiao |
| 223 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Jul―01 |
Abstract 65: Early Assessment of the Pandemic Effects on Cancer Screening Services: The International Cancer Screening Network COVID-19 Survey |
Douglas M. Puricelli Perin, K. Miriam Elfström, Mireille J. M. Broeders |
| 224 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 715: Flow cytometry analysis of immune response to COVID-19 vaccine candidates using an in vitro stimulation model |
Xiaoshan Shi, Scott J. Bornheimer, Suraj Saksena, Stephanie Widmann, Aaron Tyznik |
| 225 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Jul―01 |
Abstract 18: Cancer Control Assessments in Low- and Middle-Income Countries during COVID-19: The IAEA-IARC-WHO imPACT Review Hybrid Modality |
Marianna Nobile, Kendall Siewert, Maria Tena Perpina, Yuliya Lyamzina |
| 226 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 712: Anticancer natural compounds as potential inhibitors of novel coronavirus (COVID19) main protease: An in-silico study |
Amaresh Mishra, Yamini Pathak, Gourav Choudhir, Anuj Kumar, Surabhi Kirti Mishra, Vishwas Tripathi |
| 227 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 706: Rapid detection of SARS-CoV-2 antigen and antibody seroconversion in clinical specimens using a novel Surface Programmable Activation Receptor (SPAR) modified T cell diagnostic method |
Aaron K. LeFebvre, Melissa Frenchmeyer, Kyle M. McQuaid, MRussell Williams, Charles M. McBrairty, Joseph D. Kittle |
| 228 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 713: Inhibition of pseudo SARS-CoV-2 binding activity of a anti-cancer polypharmacological agent analogs |
Rao V. Papineni, Amitava Adhikary, Ritesh Tandon, Dipanwita Mitra |
| 229 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 707: Detection of SARS-CoV-2 co-infections with seasonal respiratory viruses using a multiplexed amplicon NGS panel |
Lucie S. Lee, Rounak Feigelman, David Debruyne, Julia Spencer, Chenyu Li, Zhitong Liu, Guoying Liu |
| 230 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 701: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score |
Gino M. Dettorre, Saoirse Dolly, Angela Loizidou, John Chester, Amanda Jackson, Uma Mukherjee, Alberto Zambelli, Juan Aguilar-Company, Mark Bower, Christopher C. Sng, Ramon Salazar, Alexia Bertuzzi, Joan Brunet, Ricard Mesia, Ailsa Sita-Lumsden, Elia Seguí, Federica Biello, Daniele Generali, Salvatore Grisanti, Pavetha Seeva, Gianpiero Rizzo, Michela Libertini, Antonio Maconi, Charlotte Moss, Josep Tabernero, Beth Russell, Nadia Harbeck, Bruno Vincenzi, Rossella Bertulli, Diego Ottaviani, Raquel Liñan, Andrea Marrari, M. Carmen Carmona-García, Neha Chopra, Carlo Tondini, Oriol Mirallas, Valeria Tovazzi, Vittoria Fotia, Claudia Andrea Cruz, Nadia Saoudi-Gonzalez, Eudald Felip, Ariadna Roqué, Alvin J. Lee, Thomas Newsom-Davis, Andrea Patriarca, Lorenza Rimassa, Armando Santoro, Alessandra Gennari, Nikolaos Diamantis, David J. Pinato |
| 231 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 705: SARS-CoV-2 infection of the human heart governs intracardiac innate immune response |
Anthony W. Ashton, Liang Zhang, Yan Liang, Prajan Divakar, Carolos Cordon-Cardo, Richard G. Pestell |
| 232 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract LB075: Development of SARS-CoV-2 neutralizing protein by ACE2 receptor engineering for severe infection and patients with underlying diseases |
Byoung S. Kwon, Seunghyun Lee, Jin-Kyung Choi, Bora Hwang, Sun-Woo Im, Yun-Sook Lim, Bumseok Kim, Soon B. Hwang, HoonSung Jeh |
| 233 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract LB072: SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus |
Zhiqiang Qin, Jungang Chen, Lu Dai, Lindsey Barrett, Steven Post |
| 234 |
[GO] |
Cancer Research |
2021―Jul―01 |
Abstract 702: Single-cell expression landscape of SARS-CoV-2 receptor ACE2 and host proteases in human lung adenocarcinoma |
Guangchun Han, Ansam Sinjab, Kieko Hara, Warapen Treekitkarnmongkol, Patrick Brennan, Kyle Chang, Elena Bokatenkova, Beatriz Sanchez-Espiridion, Carmen Behrens, Luisa M. Solis, Boning Gao, Luc Girard, Jianjun Zhang, Boris Sepesi, Tina Cascone, Lauren A. Byers, Don L. Gibbons, Jichao Chen, Seyed Javad Moghaddam, Edwin J. Ostrin, Paul Scheet, Junya Fujimoto, Jerry Shay, John V. Heymach, John D. Minna, Steven Dubinett, Ignacio I. Wistuba, Christopher S. Stevenson, Avrum E. Spira, Linghua Wang, Humam Kadara |
| 235 |
[GO] |
Clinical Cancer Research |
2021―Jun―09 |
A Neoadjuvant Chemotherapy Trial for Early Breast Cancer is Impacted by COVID-19: Addressing Vaccination and Cancer Trials Through Education, Equity, and Outcomes |
David A. Potter, Alexandra Thomas, Hope S. Rugo |
| 236 |
[GO] |
Cancer Discovery |
2021―Jun―04 |
COVID-19 Reshapes Cancer Clinical Research |
|
| 237 |
[GO] |
Cancer Discovery |
2021―May―19 |
Preexisting and post-COVID-19 immune responses to SARS-CoV-2 in cancer patients |
Tatjana Bilich, Malte Roerden, Yacine Maringer, Annika Nelde, Jonas S Heitmann, Marissa L Dubbelaar, Andreas Peter, Sebastian Horber, Jens Bauer, Jonas Rieth, Marcel Wacker, Fiamma Berner, Lukas Flatz, Stefanie Held, Peter Brossart, Melanie Marklin, Philipp Wagner, Eva Erne, Reinhild Klein, Hans-Georg Rammensee, Helmut R Salih, Juliane S. Walz |
| 238 |
[GO] |
Cancer Discovery |
2021―May―14 |
Blood Cancers Diminish Response to COVID-19 Vaccine |
|
| 239 |
[GO] |
Cancer Prevention Research |
2021―Apr―28 |
Q&A: Ned Sharpless on COVID-19 and Cancer Prevention |
|
| 240 |
[GO] |
Cancer Discovery |
2021―Apr―12 |
Repurposing of anticancer drugs expands possibilities for antiviral and anti-inflammatory discovery in COVID-19 |
Mihaela Aldea, Jean-Marie Michot, Francois-Xavier Danlos, Antoni Ribas, Jean-Charles Soria |
| 241 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Apr―02 |
Voices of Community Organizations: How Cancer Centers Can Support Communities in the Face of COVID-19 |
JD Austin, E Lee, RC Shelton, G Hillyer, K Schmitt, P Tehranifar |
| 242 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Apr―02 |
Financial and Employment Impacts of Cancer and COVID-19 Among African American Cancer Survivors |
TA Hastert, JJ Ruterbusch, AL Best, FWK Harper, H Thompson, JL Beebe-Dimmer, AG Schwartz |
| 243 |
[GO] |
Cancer Discovery |
2021―Apr―02 |
Treatment Decisions for Patients with Cancer during the COVID-19 Pandemic |
Chris Labaki, Solange Peters, Toni K. Choueiri |
| 244 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Apr―02 |
Impact of COVID-19 Pandemic on Healthcare Delivery, Behavioral Outcomes, and Financial Stress in 1,253 Individuals with Cancer at Huntsman Cancer Institute (HCI) |
AR Peoples, C Himbert, CA Hathaway, AC Kirchhoff, J Ose, T Lin, H Colman, KB Jones, WL Akerley, D Grossman, JP Hunt, FJ Penedo, EM Siegel, CM Ulrich, SS Tworoger |
| 245 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Apr―02 |
Improving Survey Response Rates Among Patients at a Cancer Center During a Global Pandemic |
CA Hathaway, EM Siegel, B Gonzalez, SS Tworoger |
| 246 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P30: Long-term outcomes of cancer patients infected with COVID-19 |
Justin Shaya, Angelo Cabal, Pedram Razavi, Rana R. McKay |
| 247 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P22: A high-throughput anti-SARS-CoV-2 IgG testing platform for COVID-19 |
Jinwei Du, Eric Chu, Dayu Zhang, Chuanyi M. Lu, Aiguo Zhang, Michael Sha |
| 248 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P08: Adenosine-based cancer immunotherapy for COVID-19 |
Giulia Monticone, Alistair Ramsay, Lucio Miele |
| 249 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P12: Colorectal cancer screening in Appalachian Kentucky primary care clinics during COVID-19 |
Aaron J. Kruse-Diehr, Mark Cromo, Melinda Rogers, Angela Carman, Bin Huang, David Gross, Sue Russell, Vickie Fairchild, Mark Dignan |
| 250 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P41: Mental health and coping during COVID-19 among cancer patients and survivors |
Jeanine P.D. Guidry, Carrie A. Miller, Bernard F. Fuemmeler |
| 251 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S11-02: Factors associated with developing COVID-19 among cancer patients in New York City |
Monica F. Chen, Monica T. Coronel, Samuel Pan, Arreum Kim, Jessica Hawley, Gary Schwartz, Katherine Crew |
| 252 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S09-04: Asymptomatic detection of COVID-19 among cancer patients receiving infusional anti-cancer therapy |
Justin A. Shaya, Angelo Cabal, Francesca Torriani, Joseph Califano, Scott Lippman, Assuntina Sacco, Rana R. McKay |
| 253 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S09-02: High incidence of persistent COVID-19 among patients with lymphoma treated with B-cell depleting immunotherapy |
Sylvain Lamure, Remy Dulery, Marc Delord, Roberta Di Blasi, Adrien Chauchet, Thomas Hueso, Cédric Rossi, Bernard Drenou, Bénédicte Deau-Fischer, Carole Soussain, Pierre Feugier, Nicolas Noel, Sylvain Choquet, Serge Bologna, Bertrand Joly, Laure Philippe, Milena Kohn, Sandra Malak, Guillemette Fouquet, Etienne Daguindau, Sophie Bernard, Yassine Taoufik, Karine Lacombe, Guillaume Cartron, Catherine Thieblemont |
| 254 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P24: Evidenced-based natural therapies and immune-enhancing strategies to control, prevent, and treat co-morbidities COVID-19 and cancer |
Padma P. T. Uppala, Sherri Isaak, Brian Wong, Kimberly Ferreira, Carlos Garberoglio, John Kelly |
| 255 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S06-02: Disruption to care of patients with thoracic malignancies: A COVID-19 and cancer outcomes study |
Sheena Bhalla, Ziad Bakouny, Andrew L. Schmidt, John A. Steinharter, Douglas A. Tremblay, Mark M. Awad, Alaina J. Kessler, Robert I. Haddad, Michelle Evans, Fiona Busser, Michael Wotman, Catherine R. Curran, Brittney S. Zimmerman, Gabrielle Bouchard, Tomi Jun, Pier V. Nuzzo, Qian Qin, Laure Hirsch, Jonathan Feld, Kaitlin M Kelleher, Danielle Seidman, Hsin-Hui Huang, Chris Labaki, Heather M. Anderson-Keightly, Sarah Abou Alaiwi, Talia D. Rosenbloom, Penina S. Stewart, Matthew D. Galsky, Toni K. Choueiri, Deborah B. Doroshow |
| 256 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P25: Prostate cancer and COVID-19 outcomes: Results from the Cleveland Clinic registry of COVID-19 and cancer patients |
Scott J. Dawsey, Nathan A. Pennell, Christopher Lemmon, Amanda Nizam, Wei Wei, Timothy D. Gilligan, Moshe C. Ornstein, Shilpa Gupta |
| 257 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S11-04: Using CXR-Net to detect COVID-19 and non-COVID-19 patients |
Benjamen Huber, Abdulah Haikal, Domenico Gatti, Hamid Soltanian-Zadeh |
| 258 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S10-03: Adolescent and young adult cancer patient and survivor employment changes during COVID-19 are associated with financial toxicity |
Austin Waters, Heydon Kaddas, Karely Mann, Perla L. Vaca Lopez, Echo L. Warner, Joemy Ramsay, Judy Ou, Nicole Ray, Tomoko Tsukamoto, Douglas B. Fair, Joseph M. Letourneau, Mark A. Lewis, David A. Gill, Lauri Linder, Anne C. Kirchhoff |
| 259 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P23: Detection of humoral and cellular responses to SARS-CoV-2 in COVID-19 convalescents |
Anna Baranska, Marc Schuster, Marek Wieczorek, Sebastian Flade, Lennart Wessels, Burhan Karaca, Verena Traska, Mario Assenmacher, Gregor Winkels |
| 260 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S12-03: Clinical and demographic characteristics associated with shorter time to COVID-19 death |
Maria J. Monroy-Iglesias, Beth Russell, Charlotte Moss, Gincy George, Kieran Palmer, Sophie Papa, Sheeba Irshad, Paul Ross, James Spicer, Sharam Kordasti, Danielle Crawley, Harriet Wylie, Fidelma Cahill, Anna Haire, Rushan Sylva, Kamarul Zaki, Fareen Rahman, Ailsa Sita-Lumsden, Debra Josephs, Deborah Enting, Mary Lei, Sharmistha Ghosh, Claire Harrison, Angela Swampillai, Elinor Sawyer, Andrea D'Souza, Simon Gomberg, Paul Fields, David Wrench, Kavita Raj, Mary Gleeson, Kate Bailey, Richard Dillon, Matthew Streetly, Austin Kulasekararaj, Thinzar Ko Ko, Vallari Shah, Anne Rigg, Richard Sullivan, Mieke Van Hemelrijck, Saoirse Dolly |
| 261 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S12-04: COVID-19 disease in patients with lung cancer in Spain: GRAVID Lung Cancer Patients Disease (GRAVID study) |
Jose Maria Mazarico Gallego, Antonio Calles, Monica Antoñanzas, Cristina Pangua, Xabier Mielgo Rubio, Ernest Nadal, Rafael Lopez Castro, Ana Lopez-Martin, Edel del Barco, Manuel Domine, Virginia Calvo, Pilar Diz, Carmen Sandoval, Elia Sais Girona, Ivana Gabriela Sullivan, M. Angeles Sala, Gema Garcia Ledo, Jose Ramon Jarabo, Rosa Alvarez Alvarez, Javier Baena, Maria Gonzalez-Cao, Mariano Provencio |
| 262 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P06: Anticancer agent 3-deazauridine has the potential to be effective against COVID-19 due to its inhibition of replication of RNA viruses |
Richard Momparler |
| 263 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S12-06: Social Determinants of Health (SDOH) barriers as predictors of intent to vaccinate for COVID-19 in a vulnerable population |
Beth A. Jones, William Eger, Sakinah Suttiratana, Roy Herbst, Eiman Ibrahim, Hannah Behringer, Rachel A. Clare |
| 264 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S12-05: Prevalence of COVID-19 in asymptomatic cancer patients on active systemic treatment in a public Brazilian hospital: The impact of socioeconomic status |
Luiza Fadul, Barbara Benetton, Larissa Furlan, Marina Topanotti, Marcia Lanza, Mauricio Nogueira, Aline Fares, Daniel Araujo |
| 265 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P11: The elevated level of the main markers of neutrophil extracellular traps in metastatic colorectal cancer plasma highlights the enhanced risk of severe forms of COVID-19 in cancer patients |
Alain R. Thierry, Brice Pastor, Jean-Daniel Abraham, Ekaterina Pisareva, Thibault Mazard |
| 266 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P33: Disparities in breast cancer screening and the impact of COVID-19 in Houston, Texas |
Maryam Nemati Shafaee, Luke Gilman, Abiodun Oluyomi, Melissa Bondy, Tamara Ortiz-Perez, Chris Amos, Mothaffar Rimawi |
| 267 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S06-03: Outcomes of COVID-19 in patients with cancer: Results of a prospective observational comparison of routine screening strategy versus testing based on clinical suspicion |
Zhuoer Xie, Antoine N. Saliba, Jithma Abeykoon, Umair Majeed, Daniel Almquist, Julia Wiedmeier-Nutor, Evandro Bezerra, Xavier Andrade-Gonzalez, Ashley Hickman, Karl Sorenson, Sagar Rakshit, Christopher Wee, Sri Tella, Anuhya Kommalapati, Nadine Abdallah, Joshua Pritchett, Mariza De Andrade, Dipesh Uprety, Andrew Badley, Joleen Hubbard, Naseema Gangat, Carrie A. Thompson, Thomas Witzig, Robert R. McWilliams, Konstantinos Leventakos, Thorvardur R. Halfdanarson |
| 268 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S11-03: The impact of COVID-19 in the cancer population stratified by age: A real-world data study from Guy’s Cancer Center |
Rushan Sylva, Beth Russell, Charlotte Moss, Gincy George, Kieran Palmer, Vallari Shah, Thinzar Ko Ko, Tania Kalsi, Danielle Harari, Luigi De Michele, Shahram Kordasti, Danielle Crawley, Harriet Wylie, Fidelma Cahill, Anna Haire, Andrea D'Souza, Simon Gomberg, Austin Kulasekararaj, Mieke Van Hemelrijck, Saoirse Dolly |
| 269 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P43: Clinical characteristics of COVID-19 infected cancer patients: A retrospective study in Royal Wolverhampton NHS Trust, United Kingdom |
Menna M. Fouda, Ankit Jain |
| 270 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P42: Construction of a risk map to understand the vulnerability of various types of cancer patients to COVID-19 infection |
Jian He, Mei Meng, Yiyang Zhao |
| 271 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P28: COVID-19 infection and mortality in patients with skin malignancies receiving systemic anti-cancer therapy (SACT): The Guy’s Cancer Centre experience |
Lucy Flanders, Beth Russell, Charlotte Moss, Kieran Palmer, Rushan Sylva, Gincy George, Danielle Crawley, Harriet Wylie, Fidelma Cahill, Anna Haire, Andrea D'Souza, Simon Gomberg, Richard Sullivan, Anne Rigg, Mieke Van Hemelrijck, Mark Harries, Irene De Francesco, Stephen Morris, Sophie Papa, Saiorse Dolly |
| 272 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S12-02: Comprehensive meta-analysis of COVID-19 mortality rates for 22 cancer subtypes from the Reboot: COVID-Cancer Project, an interactive resource with aggregated data from 21,839 cancer patients |
Emily-Claire Duffy, Kelly Fan, Shailesh Advani, Chris Bailey, James R.M. Black, Ellie Strauss, Devon Crittenden, Thomas Bhangdia, Allyson Imbacuan, Emily Yang, Allison Britt, Pradeep Mangalath, Charles Swanton, Laura B. Kleiman, Catherine Del Vecchio Fitz |
| 273 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S12-01: Quantifying the impact of COVID-19 on cancer care: Pathology volume change in SEER cancer registries |
Todd Golden, Linda Coyle, Jennifer Stevens, Serban Negoita |
| 274 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P05: EpistoNet: An ensemble of deep convolutional neural networks using mixture of discriminative experts for detecting COVID-19 on chest X-ray images |
Seyed Ziae Mousavi Mojab, Seyedmohammad Shams, Farshad Fotouhi, Hamid Soltanian-Zadeh |
| 275 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P44: Factors affecting COVID-19 outcomes in cancer patients from Guy’s Cancer Center and King's College Hospital |
Kieran Palmer, Rushan Sylva, Beth Russell, Charlotte Moss, Vallari Shah, Thinzar Ko Ko, Gincy George, Shahram Kordasti, Danielle Crawley, Harriet Wylie, Fidelma Cahill, Anna Haire, Kamarul Zaki, Ailsa Sita-Lumsden, Debra Josephs, Deborah Enting, Angela Swampillai, Elinor Sawyer, Mary Lei, Andrea D’Souza, Simon Gomberg, Paul Fields, David Wrench, Richard Sullivan, Anne Rigg, Austin Kulasekararaj, Mieke Van Hemelrijck, Saoirse Dolly |
| 276 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S06-04: Telehealth experiences of adolescent and young adult cancer patients and survivors during the COVID-19 pandemic |
Karely Mann, Austin R. Waters, Perla L. Vaca Lopez, Echo L. Warner, Judy Ou, Heydon Kaddas, Joemy Ramsay, Nicole Ray, Tomoko Tsukamoto, Douglas B. Fair, Joseph M. Letourneau, Mark A. Lewis, David Gill, Lauri Linder, Anne C. Kirchhoff |
| 277 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P40: PTSD and levels of general anxiety in Italian oncological patients during the COVID-19 pandemic |
Mariam Chichua, Eleonora Brivio, Serena Oliveri, Paolo Guiddi, Gabriella Pravettoni |
| 278 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S02-04: Drive By Flu-FIT: A novel way to mitigate the decrease in colorectal cancer screening during the COVID-19 pandemic |
Armenta Washington, Leroy Miles, Claudia Melendez, Brenda Bryant, Alexander Auchus, Michael Goldberg, Scott Melnick, Juanita Way, Danielle Grant, Kimberly Highsmith, Carmen E. Guerra |
| 279 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S10-04: Disparities in food insecurity among cancer survivors during the U.S. COVID-19 pandemic |
Marlene Camacho-Rivera, Jessica Y. Islam, Denise C. Vidot |
| 280 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P27: Effect of paclitaxel in gefitinib-resistant non-small cell lung cancer (NSCLC) treatment during the COVID-19 pandemic |
Md Mohiuddin, Kazuo Kasahara |
| 281 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S04-02: Effects of demographic and behavioral factors on social isolation in a cancer center population during COVID-19 pandemic |
Cassandra A. Hathaway, Brian D. Gonzalez, Amanda Bloomer, Erin M. Siegel, Cornelia M. Ulrich, Anita R. Peoples, Frank J. Penedo, Shelley S. Tworoger |
| 282 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P17: Effect of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic |
Vivek U. Nimgaonkar, Abigail T. Berman, Peter Gabriel, John Kucharczuk, Lawrence N. Shulman, Charu Aggarwal, Melina E. Marmarelis |
| 283 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S02-02: The impact of resuming the breast cancer screening program in the Netherlands on breast cancer incidence and stage after its discontinuation due to the COVID-19 pandemic |
Anouk H. Eijkelboom, Linda de Munck, Marc B.I. Lobbes, Jelle Wesseling, Carla H. van Gils, Pieter J. Westenend, Cristina Guerrero Paez, Ruud M. Pijnappel, Helena M. Verkooijen, Mireille J.M. Broeders, Sabine Siesling |
| 284 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P36: Virtual cancer care in a tertiary care academic centre in Ireland during the COVID-19 pandemic - An analysis of physician and patient opinion |
Mary N. O'Reilly, Mark Doherty |
| 285 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S09-03: Real world data analysis of patients with genitourinary cancers receiving systemic anticancer treatment during the COVID-19 pandemic at Guy's Cancer Centre: A single centre retrospective study in the UK |
Christina Karampera, Beth Russell, Charlotte Moss, Rushan Sylva, Kieran Palmer, Elias Pintus, Sarah Rudman, Debra Josephs, Kamarul Zaki, Mieke Van Hemelrijck, Saoirse Dolly, Deborah Enting |
| 286 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P19: Systemic anticancer treatment changes at the start of the COVID-19 pandemic in a large Australian metropolitan health service |
Elizabeth Liow, Cameron McLaren, Samuel Tipping-Smith, Sarah Latham, Jun Beng Kong, Marissa Lam, Caroline Lum, Amy Body, Peter Briggs, Eva Segelov |
| 287 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P15: Treatment (TX) of advanced melanoma during the Coronavirus Disease 2019 (COVID-19) pandemic in Kaiser Permanente Northern California (KPNC) |
Juraj Kavecansky, Nina Shah, Angeles Price, Frank Hsieh, Alice Kengla, Belinda Ark, Jahan Tavakoli, Christine Kaiser, Mingqing Li, Sejal Jhatakia, Mala Reddy, Dazhi Cen, Philip Sardar, Stephen Wang, Ashok Pai, Andrea Harzstark, Tatjana Kolevska, Thach-Giao Truong |
| 288 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S02-03: The impact of the COVID-19 pandemic on Barrett’s esophagus and esophago-gastric cancer |
Richard C. Turkington, Anita Lavery, David Donnelly, Anna T. Gavin, Damian T. McManus, Victoria Cairnduff, Charlene M. McShane, Brian T. Johnston, Lesley A. Anderson, Helen G. Coleman |
| 289 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P45: A global snapshot of the impact of the COVID-19 pandemic on cancer research: Report from a Global Cancer and COVID-19 Task Force |
Louis Fox, Verna Vanderpuye, Richard Sullivan, Mieke Van Hemelrijck, Deborah Mukherji |
| 290 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S04-03: Impact of the COVID-19 pandemic on social and health behaviors among rural and urban cancer patients at Huntsman Cancer Institute (HCI) |
Bailee Daniels, Caroline Himbert, Cassandra A. Hathway, Tengda Lin, Karen Salas, Anjelica Ashworth, Anne C. Kirchhoff, Anna Beck, Cindy Matsen, Courtney Scaife, Cristina Christenson, Douglas Grossman, Howard Colman, Jason P. Hunt, Jennifer Ose, Jonathan Tward, Kevin B. Jones, Michael Deininger, Mikaela Larson, Paul LaStayo, Thomas Varghese, Tracy Onega, Wallace L. Akerley, Frank J. Penedo, Erin M. Siegel, Cornelia M. Ulrich, Shelley S. Tworoger, Anita R. Peoples |
| 291 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P32: Inequalities in the decline and recovery of pathological cancer diagnoses during the first six months of the COVID-19 pandemic: A population-based study |
Ashleigh C. Hamilton, David W. Donnelly, Maurice B. Loughrey, Richard C. Turkington, Colin Fox, Deirdre Fitzpatrick, Ciaran E. O'Neill, Anna T. Gavin, Helen G. Coleman |
| 292 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S10-02: Financial hardship and mental health among cancer survivors during the COVID-19 pandemic: An analysis of the U.S. COVID Impact Survey |
Jessica Y. Islam, Denise C. Vidot, Marlene Camacho-Rivera |
| 293 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P02: Predicting mortality in SARS-CoV-2 (COVID-19) positive patients in the inpatient setting using a Novel Deep Neural Network |
Fahad S. Ahmed, Maleeha Naseem, Hajra Arshad, Syeda Amrah Hashmi, Furqan Irfan |
| 294 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P26: Re-analyzing randomized trials with incorporation of COVID-19 risk associated with cancer therapy |
Shervin Tabrizi, Lorenzo Trippa, Daniel Cagney, Ayal A. Aizer, Shyam Tanguturi, Steffen Ventz, Geoffrey Fell, Jennifer R. Bellon, Harvey Mamon, Paul Nguyen, Anthony V. D'Amico, Daphne Haas-Kogan, Brian M. Alexander, Rifaquat Rahman |
| 295 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P04: Effects of COVID-19 treatments on cancer: A machine learning approach to synthesize clinical evidence at scale |
Allison Britt, Emily Yang, Devon Crittenden, Thomas Bhangdia, Ben Nye, Emily-Claire Duffy, Saradha Miriyala, Emily van der Veen, Sam Marchant, Kelly Fan, Ellie Strauss, Katherine McKinley, Kriti Sharda, Murshea Tuor, Ishita Mahajan, Noopur Ranganathan, Lailoo Perriello, Byron Wallace, Pradeep Mangalath, Laura B. Kleiman, Catherine Del Vecchio Fitz |
| 296 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S05-02: Plant viral nanoparticle-based adjuvants for cancer immunotherapy and COVID-19 vaccines |
Nicole F. Steinmetz, Jonathan K. Pokorski, Steven N. Fiering, P. Jack Hoopes, Sourabh Shukla, Oscar A. Ortega-Rivera, Steven King, Cyril J. Empig |
| 297 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P38: An examination of COVID-19-related preventive behaviors by cancer status |
Carrie A. Miller, Jeanine P.D. Guidry, Bernard F. Fuemmeler |
| 298 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P34: Health care disparities and outcomes of cancer patients with COVID-19: A pooled analysis of two Brazilian tertiary centers |
Marina Topanotti, Larissa L. Furlan, Catarina Marchon, Pedro Amaral, Barbara C. Beneton, Luiza A. Fadul, Maria Lucia Salomao, Suzana M. Lobo, Aline F. Fares, Daniel V. Araújo, Eliza D. Ricardo |
| 299 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P18: Radical cancer treatment is safe during COVID-19: The experience of a large London-based Comprehensive Cancer Centre |
Beth Russell, Victoria Harris, Harvey Dickinson, Charlotte Moss, Graham Roberts, Kate Haire, Eirini Tsotra, Harris Gousis, Debra Josephs, Deborah Enting, Ailsa Sita-Lumsden, Jose Roca, Vasilliki Michalaera, Mary Lei, Angela Swampillai, Eleanor Sawyer, Daniel Smith, Irene De Francesco, Teresa Guerrero-Urbano, Mieke Van Hemelrijck, Saoirse Dolly |
| 300 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P20: Continuity of oncology clinical trials during the Coronavirus Disease-2019 pandemic in Korea |
Hee Kyung Ahn, Soohyeon Lee, Seon-A Jang, Ji-Yeon Kim, Jin Seok Ahn, Yeon Hee Park |
| 301 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S03-04: Spatial profiling of lung SARS-CoV-2 and influenza virus infection identifies virus specific host responses and gene signatures |
Arutha Kulasinghe |
| 302 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P21: Saliva as a testing specimen with or without pooling for SARS-CoV-2 detection by multiplex RT-PCR test |
Qing Sun, Jonathan Li, Hui Ren, Larry Pastor, Yulia Loginova, Joseph Wong, Zhao Zhang, Aiguo Zhang, Chuanyi Mark Lu, Michael Sha |
| 303 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S03-02: Adaptive immunity to SARS-CoV-2 in cancer patients: The CAPTURE study |
Lewis Au, Annika Fendler, Laura Amanda Boos, Fiona Byrnes, Scott Shepherd, Emma Nicholson, Scaheen Kumar, Nadia Yousaf, Katalin Wilkinson, Anthony Swerdlow, Ruth Harvey, George Kassiotis, Robert Wilkinson, James Larkin, Samra Turajlic |
| 304 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S03-03: Cancer patients display diminished viral RNA clearance and altered T cell responses during SARS-CoV-2 infection |
Michael Chiorazzi, Erin Silva, Kristina Brower, Patrick Wong, Carolina Lucas, Jon Klein, Feimei Liu, Maura Nakahata, Jun Zhao, Nur-Taz Rahman, Camila Odio, Santos Bermejo, Shelli F. Farhadian, Charles Dela Cruz, Arnau Casanovas-Massana, John Fournier, Catherine Muenker, Anne L. Wyllie, Chantal B.F. Vogels, Chaney C. Kalinich, Mary E. Petrone, Isabel M. Ott, Anne E. Watkins, Adam J. Moore, Tara Alpert, Yuval Kluger, Aaron Ring, Nathan D. Grubaugh, Akiko Iwasaki, Albert I. Ko, Roy S. Herbst |
| 305 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S01-03: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score |
Gino M. Dettorre, Saoirse Dolly, Angela Loizidou, John Chester, Amanda Jackson, Uma Mukherjee, Alberto Zambelli, Juan Aguilar-Company, Mark Bower, Christopher C. T. Sng, Ramon Salazar, Alexia Bertuzzi, Joan Brunet, Ricard Mesia, Ailsa Sita-Lumsden, Elia Seguí, Federica Biello, Daniele Generali, Salvatore Grisanti, Pavetha Seeva, Gianpiero Rizzo, Michela Libertini, Antonio Maconi, Charlotte Moss, Beth Russell, Josep Tabernero, Nadia Harbeck, Bruno Vincenzi, Rossella Bertulli, Diego Ottaviani, Andrea Marrari, M. Carmen Carmona-García, Neha Chopra, Carlo Tondini, Oriol Mirallas, Valeria Tovazzi, Vittoria Fotia, Claudia A. Cruz, Nadia Saoudi-Gonzalez, Eudald Felip, Lorenza Scotti, Alvin J. X. Lee, Thomas Newsom-Davis, Andrea Patriarca, Lorenza Rimassa, Armando Santoro, Alessandra Gennari, Mieke Van Hemelrijck, Nikolaos Diamantis, David J. Pinato |
| 306 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract S01-02: Assessing vulnerability of patients with lung cancer to SARS-CoV-2 infection based on serological antibody analyses |
Amy C. Moore, Paul A Bunn, Beatriz Fontoura, Adolfo García-Sastre, Jorge Gomez, Florian Krammer, Phillip Mack, John D. Minna, Christian Rolfo, Yu Shyr, Peter Ujhazy, Fred R. Hirsch |
| 307 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P35: Targeting vimentin impacts multiple cellular processes, blocks the spike protein-ACE2-mediated pseudoviral infection in vitro and reduces the symptom and lung injury in aged mice with mouse-adapted SARS-CoV-2 infection in vivo |
Zhizhen Li, Jianping Wu, Baoshi Yuan, Kenneth Dinnon, Lian Mo, Fei Zhou, Yingying Dong, Kendra Gully, Ralph Baric, Rachel Graham, Ying Xu, Ruihuan Chen |
| 308 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P13: Prospective voluntary SARS-CoV-2 virus and anti-COVID-19 antibody tests in asymptomatic medical and research staff who work in direct contact with cancer patients: A single center study |
Weijing Sun, Andrew K. Godwin, Kathan Mehta, Natalie Streeter, Elizabeth Wulff-Burchfield, Anup Kasi, Tara L. Lin, Joaquina Baranda, Joseph McGuirk, Ziyan Pessetto, Adam Pessetto, B.J. Broome, Terry Tsue, Roy Jensen |
| 309 |
[GO] |
Clinical Cancer Research |
2021―Mar―12 |
Abstract P29: Pre-COVID-19 pandemic vs. post-COVID-19 pandemic: Sustained participation of minorities in research in a CAP accredited biorepository in UC San Diego, California |
Sharmeela A. Kaushal, David Anjakos, Mason A. Kyle, Diana Cortez-Moreno, Alfredo A. Molinolo |
| 310 |
[GO] |
Clinical Cancer Research |
2021―Mar―01 |
Vascular normalization to improve treatment of COVID-19: Lessons from treatment of cancer |
Lance L Munn, Triantafyllos Stylianopoulos, Natalie K Jain, C Corey Hardin, Melin J Khandekar, Rakesh K. Jain |
| 311 |
[GO] |
Cancer Discovery |
2021―Feb―26 |
COVID-19 Prolonged in Patients with Cancer |
|
| 312 |
[GO] |
Cancer Prevention Research |
2021―Feb―24 |
COVID-19 disruptions to endoscopic surveillance in Lynch syndrome |
Danielle B McKenna, Christina M Dudzik, Shria Kumar, Nadim Mahmud, Bryson W Katona |
| 313 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract PS7-01: Characteristics and outcomes of SARS-CoV-2 infection in patients with invasive breast cancer (BC) from the COVID-19 and cancer consortium (CCC19) cohort study |
Ali Raza Khaki, Dimpy P Shah, Maryam B Lustberg, Melissa K Accordino, Daniel G Stover, Gayathri Nagaraj, Donna R Rivera, Edith A Perez, Sara M Tolaney, Jeffrey Peppercorn, Petros Grivas, Jeremy L Warner, Corrie A Painter, Gilberto de Lima Lopes, Solange Peters, Michael A Thompson, Toni K Choueiri, Brian I Rini, Gary H Lyman, Nicole M Kuderer, Shaveta Vinayak |
| 314 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract PS12-26: “Bridge” neoadjuvant endocrine therapy for early stage breast cancer patients during COVID-19 at an academic hospital in NYC: Lessons learned |
Cindy Cen, Freya Schnabel, Sylvia Adams, Magdalena Plasilova, Janet Yeh, Marleen Meyers, James Speyer, Elliot Belenkov, Maryann Kwa, Yelena Novik, Elena Katz, Amber Guth |
| 315 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract PS8-26: The new normal; adjusting to remote ways of providing bespoke weight management support to breast cancer survivors during the COVID-19 global pandemic |
Katie Pickering, Sarah Wane, Helen Speake, Helen Crank, Annie Anderson, Henry Cain, Rob Copeland, Daniela Lee, Joanne Gray, Richard McNally, Jackie Hargreaves, Judith Cohen, Matthew Northgraves, Caroline Wilson, John Saxton |
| 316 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract SS2-03: Patterns of medical behavior in the management of breast cancer during COVID-19. Mexican Experienc |
Ricardo Villalobos Valencia, Samuel Rivera Rivera |
| 317 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract PS6-32: Impact of COVID-19 on breast cancer care at a Bay Area academic center |
Julie Wu, Sally Bobo, Solomon Henry, Meredith Mills, Allison Kurian, Frederick Dirbas |
| 318 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract SS2-10: Impact of COVID-19 on study sites: Survey analysis from the noninterventional POLARIS study |
Debu Tripathy, Joanne L Blum, Gabrielle Rocque, J. Daniel Cuevas, Jennifer Specht, Steven Corso, Jawad E Francis, Stephanie Mendez, Veneta Pope, Joseph Cappelleri, Yao Wang |
| 319 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract SS2-04: Health maintenance and breast cancer screening during the COVID-19 pandemic |
Arash Naeim, Neil Wenger, Karen Sepucha, Annette Stanton, Ryan Baxter-King, Leah Sabacan, Antonia Petruse, Patricia Choy, Susie Brain, Laura Esserman, Lynn Vavreck |
| 320 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract SS2-09: Telemedicine usability for cancer care during the COVID-19 pandemic |
Andrea Leon, Rebecca Kaltman, Hannah Arem, Richard Amdur, Andrea Gesteira, Samuel Duffy, Christian Miller, Brooke Burgess, Christiane Morecock |
| 321 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract PS2-27: Benefits of a rapid diagnostic centre for breast cancer care during the COVID-19 pandemic |
Gary Ko, Sharmy Sarvanantham, Sangita Sequeira, Vrutika Prajapati, David R. McCready, Vivianne Freitas, Tulin D. Cil |
| 322 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract PS13-30: Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic |
Franklin F Pimentel, Jessica MC Borba, Tamara CGF Rodrigues, Karoline PI Peruchi, Helio HA Carrara, Jurandyr M de Andrade, Francisco J Candido dos Reis |
| 323 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract SS2-02: Patient perception of breast and gynecologic cancer care during the SARS-CoV-2 (COVID-19) pandemic in NYC: A single center survey-based study |
Brittney S Zimmerman, Danielle Seidman, Natalie Berger, Krystal P Cascetta, Michelle Nezolosky, Kara Trlica, Alisa Ryncarz, Caitlin Keeton, Erin Moshier, Amy Tiersten |
| 324 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract SS2-08: Patient perception of telehealth services for breast and gynecologic cancer care during the SARS-CoV-2 (COVID-19) pandemic in NYC: A single center survey-based study |
Brittney S Zimmerman, Danielle Seidman, Natalie Berger, Krystal P Cascetta, Michelle Nezolosky, Kara Trlica, Alisa Ryncarz, Caitlin Keeton, Erin Moshier, Amy Tiersten |
| 325 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract PS11-21: First-line treatment trends in metastatic breast cancer before and at the early stage of the COVID-19 pandemic in the United States |
Samantha Kurosky, Xianchen Liu, Aster Meche, Rebecca Levin, Amy Sullivan, Lynn McRoy |
| 326 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract PS7-88: Effect of the COVID-19 pandemic on the initial treatment of breast cancer in the Netherlands: A population-based study |
Anouk H Eijkelboom, Linda de Munck, Marie-Jeanne Vrancken Peeters, Marjolein Smidt, Mireille Broeders, Monique Bos, Marjanka K Schmidt, Maud Bessems, Luc Strobbe, Desirée van den Bongard, Aafke Honkoop, Janneke Verloop, Cristina Guerrero Paez, Marc Lobbes, Sabine Linn, Pieter Westenend, Catharina W Menke-van der Houven van Oordt, Jelle Wesseling, Vivianne Tjan Heijnen, Sabine Siesling |
| 327 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract SS2-01: Impact of the COVID-19 pandemic on the multidisciplinary management of breast cancer: Initial analysis of the american society of breast surgeons mastery COVID-19 registry |
Lee Gravatt Wilke, Toan T Nguyen, Qiuyu Yang, Bret M Hanlon, Kathryn A Wagner, Pamela Strickland, Eric A Brown, Jill Dietz, Judy C Boughey |
| 328 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract SS2-07: Predictors for fear of cancer recurrence in breast cancer patients referred for radiation therapy during the COVID-19 pandemic: A multi-center cross-section survey |
Jinrong Xie, Weixiang Qi, Lu Cao, Yuting Tan, Jin Huang, Xiaodong Gu, Bingguang Chen, Peipei Shen, Ying Zhang, Qingwen Zhao, Hecheng Huang, Yubin Wang, Haicheng Fang, Zhenjun Jin, Hui Li, Xuehong Zhao, Xiaofang Qian, Feifei Xu, Dan Ou, Shubei Wang, Cheng Xu, Min Li, Zefei Jiang, Yu Wang, Xiaobo Huang, Jiayi Chen |
| 329 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract SS2-05: Emerging from COVID-19 pandemic: Provider perspective on use of neoadjuvant endocrine therapy (NET) in early stage hormone receptor positive breast cancer |
Ko Un Park, Megan E Gregory, Maryam B Lustberg, Jose G Bazan, Chengli Shen, Shoshana M Rosenberg, Victoria S Blinder, Priyanka Sharma, Lajos Pusztai, Ann H Partridge, Alastair Thompson |
| 330 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract PS6-47: Breast cancer and COVID-19: Impact of active treatment on severe outcomes |
Karine Tawagi, Jeff Burton, Michael Lunski, Diana Maslov, John Cole |
| 331 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract PS2-32: Incidental malignant findings on pre-admission chest computed tomography scan for coronavirus disease screening in patients with breast cancer or other cancers |
Jun Masuda, Akemi Kataoka, Katsunori Oikado, Natsue Uehiro, Yukinori Ozaki, Lina Inagaki, Chieko Kato, Hidemoto Morizono, Toshimi Takano, Takayuki Ueno, Shinji Ohno |
| 332 |
[GO] |
Cancer Research |
2021―Feb―15 |
Abstract SS2-06: Characterization of breast cancer management during the COVID 19 pandemic in a large integrated healthcare delivery system: Stage at diagnosis and timing/modality of first treatment |
Sharon B. Chang, Alison C. Savitz, Brooke Vuong, Annie Tang, Margaret Mentakis, Amy M. Miller, Veronica C. Shim, Gillian E. Kuehner |
| 333 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2021―Feb―05 |
Will COVID-19 Be the Tipping Point for Primary HPV Self-sampling? |
Anita W.W. Lim |
| 334 |
[GO] |
Clinical Cancer Research |
2021―Feb―04 |
How did we get a COVID-19 vaccine in less than one year? |
E. John Wherry, Elizabeth M. Jaffee, Nicholas Warren, Gypsyamber D'Souza, Antoni Ribas |
| 335 |
[GO] |
Cancer Discovery |
2021―Feb―02 |
Correction: Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers |
|
| 336 |
[GO] |
Cancer Immunology Research |
2021―Jan―15 |
At the Crossroads: COVID-19 and Immune Checkpoint Blockade for Cancer |
Antoni Ribas, Marina Chiara Garassino |
| 337 |
[GO] |
Blood Cancer Discovery |
2021―Jan―13 |
Cancer and COVID-19: On the Quest for Effective Vaccines |
Marwan Kwok, Edward F. Fritsch, Catherine J. Wu |
| 338 |
[GO] |
Cancer Discovery |
2020―Dec―30 |
Patients with Cancer Seroconvert Typically After SARS-CoV-2 Infection |
|
| 339 |
[GO] |
Cancer Research |
2020―Dec―22 |
Is COVID-19 - induced platelet activation a cause of concern for cancer patients? |
Lenard M. Lichtenberger, K. Vinod Vijayan |
| 340 |
[GO] |
Cancer Discovery |
2020―Dec―22 |
Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited |
Antoni Ribas, Rajarshi Sengupta, Trevan Locke, Sayyed Kaleem Zaidi, Katie M Campbell, John M. Carethers, Elizabeth M. Jaffee, E. John Wherry, Jean-Charles Soria, Gypsyamber D'Souza |
| 341 |
[GO] |
Cancer Discovery |
2020―Dec―22 |
As Pandemic Continues, Screening Concerns Grow |
|
| 342 |
[GO] |
Molecular Cancer Research |
2020―Dec―16 |
Relevance of the Bruton Tyrosine Kinase (BTK) as a target for COVID-19 therapy |
Miran Rada, Zahraa Qusairy, Marta Massip-Salcedo, Salvador Macip |
| 343 |
[GO] |
Cancer Discovery |
2020―Dec―11 |
Survival Factors ID'd for Patients with Blood Cancer + COVID-19 |
|
| 344 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2020―Dec―03 |
Abstract PO-040: Florida-California CaRE2 Health Equity Center Citizen Scientist Training Program: Going virtual in response to COVID-19 |
Nissa Askins, Fern J. Webb, Linda Behar-Horenstein, Lourdes Baezconde-Garbanati, Sandra Suther, Diana J. Wilkie, Folakemi T. Odedina |
| 345 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2020―Dec―03 |
Abstract IA10: The Prevent Anal Cancer Study: the assessment of novel opportunities for anal cancer screening during COVID-19 |
Alan G. Nyitray |
| 346 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S01-01: Therapeutic targeting of TMPRSS2 and ACE2 as a potential strategy to combat COVID-19 |
Qu Deng, Reyaz Ur Rasool, Ramakrishnan Natesan, Irfan A. Asangani |
| 347 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-069: SRMS correlated with immune infiltration and lung cancer: Allusion for COVID-19 |
Beesetti Swarna, Yong-Dong Wang, Malia B. Potts |
| 348 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-032: Patient-centered communication: Collaborative learning and communication strategies for patients and health care providers in the new normal of COVID-19 |
Martha Raymond, Margaret-Ann Simonetta |
| 349 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-011: CiRCL: A psychosocial program facilitating communication and care to patients, families, and frontline health care teams during COVID-19 |
Kauser Ahmed, Peter Phung, Noah Goldstein, John Glaspy |
| 350 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-012: Clinical features and antibody response of two pediatric patients presenting with new-onset acute myeloid leukemia and concomitant severe COVID-19 |
Pratik A. Patel, Christina A. Rostad, Stacey A. Lapp, Claire L. Stokes, Melinda G. Pauly, Evan J. Anderson, Himalee S. Sabnis |
| 351 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S10-02: Using real-world data (RWD) from an integrated platform for rapid analysis of patients with cancer with and without COVID-19 across distinct health systems |
Shirish M. Gadgeel, Michael A. Thompson, Monika A. Izano, Clara Hwang, Tom Mikkelsen, James L. Weese, Frank M. Wolf, Andrew Schrag, Sheetal Walters, Harpreet Singh, Jonathan Hirsch, Thomas D. Brown, Paul G. Kluetz |
| 352 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2020―Dec―03 |
Abstract PO-272: COVID-19 adaptations to patient navigation services for follow-up colonoscopy after an abnormal fecal test result in a community health center setting |
Jamie Thompson, Jennifer Rivelli, Amanda Petrik, Jennifer Schneider, Neha Yadav, Hanna Dinh, Cindy Pulido, Shirley Mendez, DeeDee Torres, Lakshmi Penimarthi, Gloria Coronado |
| 353 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S06-01: Changes implemented by U.S. oncology practices in response to COVID-19 pandemic: Initial report from the ASCO Registry on COVID-19 and cancer |
Suanna S. Bruinooge, Elizabeth Garrett-Mayer, Stephen Meersman, Patricia Hurley, Brian Bourbeau, Allyn Moushey, Sybil Green, Deborah Kamin, Stephen Grubbs, Richard L. Schilsky |
| 354 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract IA26: Understanding the impact of COVID in cancer patients through the COVID-19 and Cancer (CCC-19) and other COVID consortiums |
Brian I. Rini |
| 355 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-061: Data harmonization for COVID-19 and cancer research registries |
Rimma Belenkaya, Adam Watson, Shantha Bethusamy, Meera Patel, Tatyana Sandler, Julian Schwartz, James Park, Maggie Dobbins, Molly Maloy, Michael Lam, Nadia Bahadur, John Philip |
| 356 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2020―Dec―03 |
Abstract PO-263: COVID-19 and social determinants of health (SDOH): Impact on cancer prevention in vulnerable populations |
Beth A. Jones, Sakinah Suttiratana, Roy Herbst, William Eger, Eiman Ibrahim, Hannah Behringer, Eduardo Reyes, Nailah Hutchinson, Shua Kim, Jonathan Colon, Jose DeJesus, Sarah Alsup, Rachel A. Clare, Monique Killins |
| 357 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-091: CAPTURE: Cancer and COVID-19 antiviral immune monitoring study |
Annika Fendler, Laurie Boos, Lewis Au, Scott Shepherd, Fiona Byrne, Kim Edmonds, Ellie Carlyle, Lyra Del Rosario, Ben Shum, James Larkin, Lisa Pickering, Andrew Furness, Samra Turajlic |
| 358 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2020―Dec―03 |
Abstract PO-121: COVID-19, cancer, and racial health disparities |
Linda S. Behar-Horenstein, Keesha Powell-Roach, Staja Q. Booker, Michael U. Maduka, Destiny Gordon, Kayanna Jacobs, Debra Lyon |
| 359 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-019: Impact of a hospital conversion to COVID-19 center on cancer care of patients in a urologic oncology clinic in Mexico |
Salvador G. Santiesteban, Haydee Verduzco-Aguirre, Christianne Bourlon, Maria T. Bourlon |
| 360 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S12-03: Thoracic cancers international COVID-19 collaboration (TERAVOLT): Small-cell lung cancer and other rare thoracic malignancies |
Alessio Cortellini, Anne-Marie C. Dingemans, Oscar Arrieta, Javier Baena, Matteo Brighenti, Enriqueta Felip, Marina Chiara Garassino, Pilar Garrido, Carlo Genova, Federica Grosso, Leora Horn, Li-Ching Huang, Jan Van Meerbeeck, Solange Peters, Ernest Nadal, Jacobo Rogado, Yu Shyr, Marcello Tiseo, Valter Torri, Annalisa Trama, Heather Wakelee, Jennifer G Whisenant, Giuseppe Viscardi, Fabrice Barlesi, Sanjay Popat |
| 361 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2020―Dec―03 |
Abstract PO-004: Association between county-level socioeconomic characteristics and health indicators with COVID-19 deaths in Florida |
Gebre-Egziabher Kiros, Kira Gaddis |
| 362 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract IA20: Potential insights into COVID-19 disparities from the science of cancer health disparities |
John M. Carethers |
| 363 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S09-04: Unemployment and cancer screening: Baseline estimates to inform health care provision in the context of COVID-19 economic distress |
Stacey A. Fedewa, K. Robin Yabroff, Zhiyuan Zheng, Priti Bandi, Ann Goding Sauer, Robert A. Smith, Nigar Nargis, Jeffrey Drope, Ahmedin Jemal |
| 364 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-005: Barriers to implementation of virtual collection of patient-reported data in the COVID-19 era |
Karineh Kazazian, Wendy Johnston, Jessica Bogach, Carol J. Swallow |
| 365 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-042: Would dermoscopic photographs help triage teledermatology consults in the COVID-19 era? |
Myles R. McCrary, Tova Rogers, Howa Yeung, Loren Krueger, Suephy C. Chen |
| 366 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-036: Safety outcomes of resuming anticancer treatment in patients with lung cancer affected by COVID-19 illness |
Antonio Calles, Mar Galera, Inmaculada Aparicio, Manuel Alva, Marianela Bringas, Natalia Gutierrez, Javier Soto, Victoria Tirado, Rosa Alvarez |
| 367 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-027: Multi-institutional survey of COVID-19 impact in cancer care in patients and health care providers |
Sylvia V. Alarcon, Omid Salehi, Eduardo A. Vega, Vera Kazakova, Claudius Conrad |
| 368 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S07-01: Examining COVID-19 preventive behaviors among cancer survivors in the United States: An analysis of the COVID-19 Impact Survey |
Jessica Y. Islam, Marlene Camacho-Rivera, Denise C. Vidot |
| 369 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-062: Early impact of COVID-19 in cancer care: The experience of a Brazilian outpatient clinic |
Cinthya Sternberg, Bianca Vivas, Thamine Lessa Andrade, Ana Paula Vila Nova, Ana Paula Fernandes, Camila Alves, Adriana Alvez, Lise Hizumi, Simone Dias, Pablicio Nobre, Aknar Calabrich, Anelisa Coutinho, Alex Pimenta |
| 370 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S02-01: Clinical characteristics and outcomes of coronavirus 2019 disease (COVID-19) in cancer patients treated with immune checkpoint inhibitors (ICI) |
Aljosja Rogiers, Carlo Tondini, Joe M. Grimes, Megan H. Trager, Sharon Nahm, Leyre Zubiri, Neha Papneja, Arielle Elkrief, Jessica Borgers, April Rose, Johanna Mangana, Michael Erdmann, Ines Pires da Silva, Christian Posch, Axel Hauschild, Lisa Zimmer, Paola Queirolo, Caroline Robert, Karijn Suijkerbuijk, Paolo A. Ascierto, Paul Lorigan, Richard Carvajal, Osama E Rahma, Mario Mandala, Georgina V. Long |
| 371 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-021: Impact of COVID-19 in continuity of cancer treatment for lung cancer patients |
Antonio Calles, Manuel Alva, Inmaculada Aparicio, Javier Soto, Natalia Gutierrez, Marianela Bringas, Vicente Escudero, Roberto Collado, Mar Galera, Rosa Alvarez |
| 372 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-060: COVID-CANCER HUIL STUDY: Registry of oncologic patients diagnosed with Covid-19 in Infanta Leonor University Hospital in Madrid, Spain |
Jacobo Rogado, Berta Obispo, Gloria Serrano-Montero, Almudena Martin Merino, Ana Lopez-Alfonso, Cristina Pangua, Mar Pérez-Pérez, Mario Fontán-Vela, Miguel Ángel Lara |
| 373 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-059: COVID-19 in melanoma patients: Spanish register |
Maria Gonzalez-Cao, Cristina Carrera, Juan Francisco Rodriguez Moreno, Pedro Rodriguez-Jiménez, Mónica Antoñanzas Basa, Marta Feito Rodríguez, Teresa Puertolas, Eva Muñoz, José Luis Manzano, Ivan Marquez-Rodas, Juan Martín-Liberal, Ainara Soria, Pilar Lopez Criado, Almudena García Castaño, Aram Boada, Pablo Ayala de Miguel, Susana Puig, Guillermo Crespo, Pablo Luna Fra, Cristina Aguayo Zamora, Jesús Gardeazabal, Cayetana Maldonado Seral, Ana Drozdowskyj, Mariano Provencio, Alfonso Berrocal |
| 374 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S04-01: Famotidine use and quantitative symptom tracking for COVID-19 in nonhospitalized patients: A case series |
Tobias Janowitz, Eva C. Gablenz, David J. Pattinson, Timothy C. Wang, Joseph Conigliaro, Kevin J. Tracey, David A. Tuveson |
| 375 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-028: One piece of the jigsaw for the cancer recovery strategy: Prevalence of COVID-19 in patients with cancer |
Charlotte Moss, Beth Russell, Mary Lei, Sharmista Ghosh, Sophie Papa, Richard Sullivan, Mieke Van Hemelrijck, Anne Rigg |
| 376 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-031: Outcomes of COVID-19 in patients with lung cancer treated in a tertiary hospital in Madrid |
Antonio Calles, Inmaculada Aparicio, Manuel Alva, Marianela Bringas, Natalia Gutierrez, Javier Soto, Mar Galera, Rosa Alvarez |
| 377 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract IA04: COVID-19 in patients with lung cancers in New York City |
Jia Luo, Hira Rizvi, Isabel R. Preeshagul, Jacklynn V. Egger, David Hoyos, Chaitanya Bandlamudi, Mark T.A. Donoghue, Marta Łuksza, Benjamin D. Greenbaum, Jedd D. Wolchok, Mark G. Kris, Matthew D. Hellmann |
| 378 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-035: Public social media discussion of COVID-19 in relation to cancer services disruption |
Damian Eade, Laura Galimam, Mónica Fernández-Sierra, Caryn Gordon, Jason McDonough |
| 379 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-079: COVID-19 in relation to hematologic events and mortality in subset of inpatient cancer patients |
Saikrishna Gadde, Ambuga Badari, John Cole, Nikhil Manjunath |
| 380 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-086: Covid-19 in the city of Teofilo Otoni-Minas Gerais: Current panorama and future perspectives |
Laryssa Reis Coelho, Gustavo da Mata Oliveira Rezende, Virgílio Barroso de Aguiar, Vânia Soares Oliveira e Almeida Pinto, Rafael Genaro, Rafael Alvarenga Almeida, Fábio Silva de Souza, Caio César de Souza Alves, Leonel de Oliveira Pinheiro, Fernanda Arueira de Siqueira Santos, Alexandre Augusto de Assis Dutra, Ana Cândida Araújo e Silva, Rogério Fernandes Macedo |
| 381 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S09-01: Cancer and race: Two important risk factors for COVID-19 incidence as captured by the COVID Symptom Study real-time epidemiology tool |
David A. Drew, Long H. Nguyen, Wenjie Ma, Chun-Han Lo, Amit D. Joshi, Daniel Sikavi, Christina M. Astley, Karla Lee, Mary Ni Lochlainn, Maria Gomez, Sebastien Ourselin, Andrew T. Chan |
| 382 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-020: Impact of CDK 4/6i withdrawal or dose adjustment on COVID-19 incidence in HR+/HER2- mBC patients during the pandemic |
Pablo Tolosa, Ana Sanchez-Torre, Helena Bote de Cabo, Rodrigo Sánchez-Bayona, Mercedes Herrera, Ramón Yarza, Laura Lema, Luis Manso, Eva Ciruelos |
| 383 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-081: Outcomes of patients with multiple myeloma with COVID-19 infection |
Michael John Lunski, Karine Tawagi, Diana Maslov, Laura Finn |
| 384 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-067: Tissue banking from patients with SARS-CoV-2 (COVID-19) infection |
Emily F. Higgs, Blake A. Flood, Athalia R. Pyzer, Sherin J. Rouhani, Jonathan A. Trujillo, Kyle R. Cron, Alexandra Cabanov, Jessica Fessler, Jeffrey Bloodworth, Kathleen Beavis, Kiang-Teck J Yeo, Randy F. Sweis, Yuanyuan Zha, Thomas F. Gajewski |
| 385 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-025: Management of breast cancer surgery during de-escalation of COVID-19 infection |
Juana María Brenes Sánchez, Amanda López Picado, María Eugenia Olivares Crespo, José Ángel García Sáenz, Rosa María De La Plata Merlo, María Herrera De La Muela |
| 386 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S12-01: High mortality among hospital-acquired COVID-19 infection in patients with cancer: An observational cohort study from Q and British Columbia |
Arielle Elkrief, Antoine Desilets, Neha Papneja, Lena Cvetkovic, Catherine Groleau, Yahia Abdelali Lakehal, Layla Shbat, Corentin Richard, Julie Malo, Wiam Belkaid, Erin Cook, Stephane Doucet, Thai Hoa Tran, Patrice Savard, Kevin Jao, Nathalie Daaboul, Eric Bhang, Jonathan Loree, Wilson Miller, Donald Vinh, Nathaniel Bouganim, Gerald Batist, Caroline Letendre, Bertrand Routy |
| 387 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-078: Clinical characteristics and outcomes of cancer patients with COVID-19 infection: A retrospective study in a single center in the Philippines |
Jessa Gilda P. Pandy, Michelle Joane Alcantara, Frances Victoria Que, Marie Belle Francia |
| 388 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-071: Collaborating to share evidence-based COVID-19 information across lung cancer patient advocacy groups |
Amy C. Moore, Janet Freeman-Daily, Kim Norris, Becky Bunn, Jan Baranski, Cristina Chin, Upal Basu Roy |
| 389 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-051: Intracellular delivery of nuclear localization signal suppresses COVID-19 mediated inflammation by regulating expression of cytokines/chemokines |
Danbi Lee, Sanghyeon Yu, Misuk Baek, Jieun Kim, Mingu Kang, Hakyoung Park, Jaewook Lee, Seokwon Lee, Junghun Kwak, Hyemin Yu, Seungwoo Lee, Sujeong Kim, Hyewon Lee, Dasom Shin, Boram Kim, Minyoung Jung, Youngsil Choi, Daewoong Jo, Gyunam Kim, Dongho Kim |
| 390 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-070: What kills patients with severe Covid-19 might also kill patients with terminal cancer |
Lingbing Zhang |
| 391 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S11-03: Impact of COVID-19 on breast and prostate cancer screening and early detection in a large health care provider group |
Mara M. Epstein, Devi Sundaresan, Meagan Fair, Lawrence Garber, Mary Charpentier, Jerry H. Gurwitz, Terry S. Field |
| 392 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-016: Evaluating the impact of COVID-19 on medical oncology workforce and cancer care in Canada: A serial survey study |
Sharlene Gill, Bruce Colwell, Hal Hirte, Welch Stephen, Alexi Campbell, Desiree Hao |
| 393 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2020―Dec―03 |
Abstract PO-077: Impact of COVID-19 on patient navigation for cancer treatment |
Sanja Percac-Lima, Erica T. Warner, Emma C. Whited, Kelly E. Irwin, Aileen Navarrete, Carmen Benjamin, Ausubel R. Pichardo, Christopher R. Friese, Colleen Ford, Amy E. Wheeler, James Morrill, Beverly Moy |
| 394 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-089: The impact of Covid-19 on public generosity toward cancer-related crowdfunding efforts |
Katrina A. Fischer, Robert E. Miller, Sidharth Anand, John Glaspy |
| 395 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S07-02: Patient-reported outcomes of breast cancer patients during the COVID-19 outbreak in the epicenter of China: A cross-sectional survey study |
Juanjuan Li, Cesar Augusto Santa-Maria, Hongfang Feng, Lingcheng Wang, Pengcheng Zhang, Yuangbing Xu, Yuyan Tan, Zhongchun Liu, Bo Du, Meng Lan, Qingfeng Yang, Feng Yao, Yi Tu, Shengrong Sun, Xingrui Li, Chuang Chen |
| 396 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-007: Breast cancer management during COVID-19 outbreak: Learned lessons |
Juana María Brenes Sánchez, Amanda López Picado, José Ángel García Sáenz, María Eugenia Olivares Crespo, Rosa María De La Plata Merlo, María Herrera De La Muela |
| 397 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S09-03: Factors affecting COVID-19 outcomes in cancer patients: A first report from Guy’s Cancer Centre in London |
Beth Russell, Charlotte Moss, Sophie Papa, Sheeba Irshad, Paul Ross, James Spicer, Shahram Kordasti, Danielle Crawley, Harriet Wylie, Fidelma Cahill, Anna Haire, Kamarul Zaki, Fareen Rahman, Ailsa Sita-Lumsden, Debra Josephs, Deborah Enting, Mary Lei, Sharmista Ghosh, Claire Harrison, Angela Swampillai, Richard Sullivan, Anne Rigg, Saoirse Dolly, Mieke Van Hemelrijck |
| 398 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2020―Dec―03 |
Abstract PO-101: Patient experiences and opinions using teleoncology in a safety-net hospital during the COVID-19 pandemic |
Andrew Wiele, Tejal A. Patel, Sarah Rizvi, Patricia De Los Rios, Kristyn-Mae Russo, Demetria Smith, Robert Hester, Hilary Y. Ma, Alyssa Rieber |
| 399 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2020―Dec―03 |
Abstract PO-075: Barriers and facilitators to recruiting research study participants from community-based HIV/AIDS service organizations: Lessons learned during the COVID-19 pandemic |
Lisa T. Wigfall |
| 400 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2020―Dec―03 |
Abstract PO-037: Challenges and solutions in outreach activities encountered in dealing with Micronesians amid the COVID-19 pandemic |
Srue H. Wakuk |
| 401 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-056: Using MammaPrint to reduce the need for chemotherapy in early breast cancer during the COVID-19 pandemic |
Elizabeth M. Murray, Ettienne J. Myburgh, Ersan Lujinovic, Lorenza Mittempergher, Duncan J. Robertson, Josephus J. de Jager, Maritha J. Kotze |
| 402 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-065: National Clinical Trials Network biobanking during the COVID-19 pandemic |
Heather A. Lankes, Mark A. Watson, Richard C. Jordan, Nilsa C. Ramirez, Ignacio I. Wistuba, Lois Shepherd, Irina A. Lubensky, Hala Makhlouf |
| 403 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-009: Cancer-related distress among multiple myeloma patients during the COVID-19 pandemic |
Nathan W. Sweeney, Jenny Ahlstrom |
| 404 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract IA16: COVID-19 pandemic and its effect on the psychological status of cancer patients and oncologists |
Gabriella Pravettoni |
| 405 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-087: COVID-19 pandemic in Italy: Social distress and gender imbalance among health care professionals |
Rossana Berardi, Mariangela Torniai, Maria Silvia Cona, Fabiana Cecere, Rita Chiari, Valentina Guarneri, Nicla La Verde, Laura Locati, Domenica Lorusso, Erika Martinelli, Marina Garassino |
| 406 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-008: Cancer care during the COVID-19 pandemic in Southern India |
Anita Ramesh, Raji Ssoundarajan |
| 407 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S11-02: Patient-reported impact of the COVID-19 pandemic on breast cancer screening, diagnosis, and treatment: A national survey |
Erica T. Warner, Emily Restrepo, Christine Benjamin, Ricki Fairley, Laura Roudebush, Leah Eshraghi, Crystal Hertz, Simo Du, Laura Carfang |
| 408 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-040: The Effects of the COVID-19 pandemic on cancer patient encounters |
Jack W. London, Elnara Fazio-Eynullayeva, Matvey Palchuk, Corinna Mossop, Peter Sankey, Christopher McNair |
| 409 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-041: The impact of the COVID-19 pandemic on cancer patients |
Lola Rahib, Zach Kaufman, Erika Vial Monteverdi |
| 410 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S11-01: Assessing the impact of the COVID-19 pandemic on cancer patients, survivors, and caregivers |
Amy Leader, Preethi Selvan, Lisa Capparella, Rebecca Cammy, Janene Palidora, Ayako Shimada, Benjamin Leiby, Gregory Garber, Brooke Worster |
| 411 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-033: Professional and psychological impact of COVID-19 pandemic on medical and radiation oncology residents: Results of a national survey |
Marc Hilmi, Alice Boilève, Anabelle Ducousso, Morgan Michalet, Anthony Turpin, Cindy Neuzillet, Natacha Naoun |
| 412 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-023: Impact of the Covid-19 pandemic on medical oncology utilization at a busy urban academic medical center |
Sidharth Anand, Anne Walling, Neil Wenger, Katrina Fischer, Lisset Huerta-Cruz, Lisa Wilen, John Glaspy |
| 413 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-022: Impact of COVID-19 pandemic on new patient and consult visits at 20 hematology/oncology practices in the ASCO PracticeNET learning network |
Brian Bourbeau, Mou Guharoy, Elizabeth Garrett-Mayer, Stephen Grubbs, Paul Unger, Barbara McAneny, Richard L. Schilsky |
| 414 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-073: Effect of the COVID-19 pandemic on oncologists’ online CME consumption and educational needs |
Michelle A. Worst, Katie Lucero |
| 415 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-017: Evaluating the impact of the coronavirus (COVID-19) pandemic on treatment paradigms in head and neck cancer at a tertiary care hospital |
Joshua A. Thompson, Reju Joy, Joshua E. Lubek, Ranee Mehra, Jason K. Molitoris, Rodney J. Taylor, Jeffrey S. Wolf, Matthew E. Witek, Kyle M. Hatten |
| 416 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-088: COVID-19 pandemic slows launch of oncology clinical trials |
Elizabeth B. Lamont, Sheila S. Diamond, Ron G. Katriel, Jingshu Lui, Lisa Ensign, Caleb Alexander |
| 417 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-003: Early detection of breast cancer during the Covid-19 pandemic using artificial intelligence neural networks |
Subash Kumar |
| 418 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-038: Strong decline of newly diagnosed gynecologic and breast cancers during the COVID-19 pandemic: A retrospective analysis from Innsbruck, Austria |
Irina Tsibulak, Elisabeth Reiser, Christoph Ebner, Katharina Knoll, Katharina Leitner, Verena Wieser, Justina Angerer, Christian Marth |
| 419 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-080: Increasing of emergency presentation on colorectal cancer patients during COVID-19 pandemic: A retrospective study on single-center academic hospital |
Budhi Ida Bagus, Metria Ida Bagus, Setyawati Ida Ayu, Mastini Ida Ayu Kade |
| 420 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-074: Patient concerns during the COVID-19 pandemic: Lessons from the lung cancer community |
Janet Freeman-Daily, Upal Basu Roy, Kim Norris, Becky Bunn, Jan Baranski, Cristina Chin, Amy C. Moore |
| 421 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-037: SKCC medical oncology telehealth experience during Covid-19 pandemic: Lessons learned and operational changes to leverage telehealth to maintain patient access |
Avnish Bhatia, Lauren Waldman, Gregory Garber, Megan Sabonjian, Melissa Hunt, Janene Palidora, Amy Leader, Brooke Worster |
| 422 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-052: COVID-19 pandemic: Patients’ perspective during cancer treatment |
Filippo Merloni, Nicoletta Ranallo, Lucia Bastianelli, Francesca Vitarelli, Luca Cantini, Zelmira Ballatore, Giulia Ricci, Ilaria Fiordoliva, Laura Tassone, Benedetta Ferretti, Paolo Alessandroni, Michela Del Prete, Silvia Chiorrini, Safi Mobin, Rita Ficarelli, Giovanni Benedetti, Luca Faloppi, Rosa Stoico, Rossana Berardi |
| 423 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-076: Training and information during COVID-19 pandemic: The masterpiece in young oncologists |
Nicoletta Ranallo, Lucia Bastianelli, Filippo Merloni, Luca Cantini, Giulia Ricci, Zelmira Ballatore, Rossana Berardi |
| 424 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-034: Prospective planning of radiation treatment at new patient conference during the COVID-19 Pandemic: The University of Mississippi Medical Center experience |
Sanjay Joseph, Mary Nittala, Paul Roberts, Maurice King, Hiba Ahmed, Ashley Albert, Toms Thomas, Robert Allbright, Satyaseelan Packianathan, Eswarkumar Mundra, Srinivasan Vijayakumar |
| 425 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S05-01: Profound CD8 T-cell responses towards SARS-CoV-2 OFR1ab in COVID-19 patients |
Anastasia Gangaev, Steven L. Ketelaars, Sanne Patiwael, Anna Dopler, Olga I. Isaeva, Kelly Hoefakker, Sara De Biasi, Cristina Mussini, Giovanni Guaraldi, Massimo Girardis, Cami M.P. Talavera Ormeno, Paul J.M. Hekking, Neubury M. Lardy, Mireille Toebes, Robert Balderas, Ton N. Schumacher, Huib Ovaa, Andrea Cossarizza, Pia Kvistborg |
| 426 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-068: Efforts to define biochemical and pharmacologic pathways potentially beneficial to both cancer and COVID-19 patients |
Ugo Rovigatti, Amedeo Vannacci, Simone Del Corto, Ignacio Martin-Loeches, Andrea Piccin, Nizar Naji, Carmel Mothersill |
| 427 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-050: Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer |
Giulia Russo, Luca Falzone, Bruno Cacopardo, Giuseppe Nunnari, Francesco Torino, Giuseppa Scandurra, Stefania Stefani, Francesco Pappalardo, Massimo Libra |
| 428 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S12-02: Risk of morbidity and mortality in COVID-19 patients with cancer |
Naomi Alpert, Bridget Marcellino, Joseph Rapp, Wil Lieberman-Cribbin, Emanuela Taioli |
| 429 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-063: Impact of cancer history on outcomes among hospitalized COVID-19 patients: A case-control analysis |
Isaac Klein, Shoshana Rosenberg, Camille Kotton, Kerry Reynolds, Leyre Zubiri, Rachel Gaither, Hannah Freeman, Greg Kirkner, Chanu Rhee, Michael Klompas, Meghan Baker, Martha Wadleigh, Eric Winer, Ann Partridge |
| 430 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-093: Low-dose whole-lung radiation for COVID-19 pneumonia: Planned day-7 interim analysis of a registered clinical trial |
Clayton B. Hess, Zachary S. Buchwald, William Stokes, Tahseen H. Nasti, Jeffrey M. Switchenko, Brent D. Weinberg, James P. Steinberg, Karen D. Godette, David Murphy, Rafi Ahmed, Walter J. Curran, Mohammad K. Khan |
| 431 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S05-02: COVIDOSE: Low-dose tocilizumab in the treatment of COVID-19 pneumonitis |
Garth W. Strohbehn, Brian L. Heiss, Sherin J. Rouhani, Jonathan A. Trujillo, Athalia R. Pyzer, Jovian Yu, Alec J. Kacew, Alexandra Weiss, Spring Maleckar, Rachel Wright, Adriana Koziol, Bethany Martell, Keith Danahey, Theodore G. Karrison, Cuoghi Edens, Iazsmin Bauer Ventura, Natasha Pettit, Bakhti Patel, Jennifer Pisano, Mary Strek, Thomas F. Gajewski, Mark J. Ratain, Pankti D. Reid |
| 432 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-057: Cancer center support for understanding statewide COVID-19 prevalence and early detection |
Jackilen Shannon, David Bangsberg, Paul Spellman, Bridget Barnes, Jenny Lee Berry, Kim Brown, Derick DuVivier, Kathryn Goforth, Peter Graven, Christopher Peters, Kathryn Schuff, Brian Druker |
| 433 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract IA13: Treatment of COVID-19 pulmonary failure by targeting BTK |
Steven Peter Treon |
| 434 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S10-01: COVID-19 severity and outcomes in hospitalized patients with cancer at a New York City tertiary medical center: A matched cohort study |
Gagandeep Brar, Laura C. Pinheiro, Michael Shusterman, Brandon Swed, Evgeniya Reshentnyak, Orysya Soroka, Frank Chen, Samuel Yamshon, John Vaughn, Peter Martin, Doru Paul, Manuel Hidalgo, Manish A. Shah |
| 435 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-029: Operationalizing a prioritized COVID-19 testing strategy at a Canadian tertiary care cancer center |
April A. Hildebrand, Desiree Hao, Safiya Karim, Winson Y. Cheung, Don Morris, Daniel Y. C. Heng |
| 436 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S02-02: Covid-19 treatment candidate hydroxychloroquine impairs tumor response to anti-PD1 |
Simon Wabitsch, Jack C McVey, Chi Ma, Benjamin Ruf, Laurence Diggs, Bernd Heinrich, Tim F Greten |
| 437 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S01-02: Optimizing treatment for COVID-19 using computational modeling: Implications for cancer patients |
Chrysovalantis Voutouri, Mohammadreza Nikmaneshi, Melin Khandekar, Ankit B. Patel, Ashish Verma, Sayon Dutta, Triantafyllos Stylianopoulos, Lance L. Munn, Rakesh K. Jain |
| 438 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-046: Assessment of COVID-19 vaccine candidates: Prediction and validation of 174 SARS-CoV-2 epitopes |
Marek Prachar, Sune Justesen, Daniel Bisgaard Steen-Jensen, Stephan Thorgrimsen, Erik Jurgons, Ole Winther, Frederik Otzen Bagger |
| 439 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-026: Minimize impact of pandemic on radiation oncology department: Experience from a moderate-sized regional cancer program in the battle against COVID-19 virus |
Ming Pan, Khalid Hirmiz, Junaid Yousuf, Kitty Huang, Colvin Springer, Ken Schneider, Laura D’Alimonte |
| 440 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract IA09: A phase II trial to promote recovery from COVID-19 with endocrine therapy |
Catherine H. Marshall, Srinivasan Yegnasubramanian, Hao Wang, Jennifer Durham, Ting Wang, Rachel Damico, Franco R. D'Alessio, Venkataramana K. Sidhaye, Andrew Pekosz, Joseph L. Mankowski, Sabra L. Klein, Sumati Murli, Elizabeth M. Jaffee, Samuel R. Denmeade |
| 441 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-002: RUXCOVID: A phase 3, randomized, placebo-controlled study evaluating the efficacy and safety of ruxolitinib in patients with COVID-19-associated cytokine storm |
MeiLan K. Han, Rachel Ann Bender Ignacio, Amparo Lopez Bernus, Katrin Milger-Kneidinger, Amesika N. Nyaku, Ben Parker, Victoria Potter, Sinisa Savic, Valerie Campello-Iddison, Weihua Cao, Peter Langmuir, Barbara Knorr |
| 442 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-085: Sex bias in COVID-19-associated Illness severity and mortality in cancer patients: A systematic review and meta-analysis |
Robin Park, Anusha Chidharla, Kathan Mehta, Weijing Sun, Anup Kasi |
| 443 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S10-03: Increased risk of COVID-19-related death among cancer survivors |
Jie Shen, Hua Zhao |
| 444 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-082: Preliminary analysis of factors associated with COVID-19-related disease severity in cancer patients: University of Kansas Cancer Center experience |
Anup Kasi, Elizabeth Wulf-Burchfield, Natalie Streeter, Stephen Jackson, David Streeter, Eric Crowder, Kathan Mehta, Weijing Sun |
| 445 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S07-04: Impact of COVID-19-related psychosocial distress on health-related quality of life in rural cancer survivors |
Scherezade K. Mama, Michelle Cardel, Kathryn H. Schmitz |
| 446 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-083: Prostate cancer and COVID-19: Impact of hormonal therapy on severe outcomes |
Karine Tawagi, Jeff Burton, Diana Maslov, Michael Lunski, Marc Matrana, Daniel Johnson |
| 447 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-045: Multiplex analysis of coronavirus and influenza antibodies using the ZIVA multiplex platform |
Jon Schmuke, Ben Miller, Linda Meeh, Byran Witherbee |
| 448 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S06-03: Cancer care telehealth utilization rates and provider attitudes in the wake of the novel coronavirus pandemic: The Kaiser Permanente Northern California experience |
Elad Neeman, Tatjana Kolevska, Mary Reed, Tilak Sundaresan, Amit Arora, Yan Li, Samantha Seaward, Gillian Kuehner, Sharon Likely, Julia Trossman, Christine Weldon, Raymond Liu |
| 449 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S03-01: Pan-HLA prediction of SARS-CoV-2 epitopes |
Katie M. Campbell, Gabriela Steiner, Daniel K. Wells, Antoni Ribas, Anusha Kalbasi |
| 450 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-004: A double-edged sword: Prolonged detection of SARS-COV-2 in patients receiving cancer-directed therapy |
Winston Wong, Claire Brevia, Michael May, Susan Whittier, Eldad Hod, Ilenia Pellicciotta, Gary K. Schwartz, Maura Abbott, Gulam A. Manji |
| 451 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S02-03: SARS-CoV-2 induces inflammatory cytokine release, which may be exacerbated by immune checkpoint blockade |
Layne Weatherford, Maria Lehn, McKenzie Crist, Chelsea Wendling, Kristin Hudock, Vinita Takiar, Trisha Wise-Draper |
| 452 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S09-02: Outcomes by race for cancer patients hospitalized with SARS-CoV-2 infection |
Steven S. Chang, Clara Hwang, Mohamed A. Elshaikh, Amy Tang, Christine M. Neslund-Dudas, Albert M. Levin, Laila M. Poisson, Benjamin A. Rybicki |
| 453 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S04-02: Treatment with tocilizumab does not inhibit induction of anti-COVID-19 antibodies in patients with severe SARS-CoV-2 infection |
Alexandra Cabanov, Blake A. Flood, Jeffrey Bloodworth, Emily F. Higgs, Jessica Fessler, Michael Y.K. Leung, Kyle R. Cron, Jonathan Trujillo, Athalia R. Pyzer, Sherin Rouhani, Garth Strohbehn, Brian Heiss, Mark Ratain, Pankti Reid, Kiang-Teck J. Yeo, Randy F. Sweis, Yuanyuan Zha, Thomas F. Gajewski |
| 454 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S01-03: A prediction of prostate cancer deaths spiking by SARS-CoV-2 infection |
Alakesh Bera, Eric Russ, Digonto Chatterjee, John Karaian, Madhan Subramanian, Sreejato Chatterjee, Surya Radhakrishnan, Michael Eklund, Harvey Pollard, Meera Srivastava |
| 455 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract IA03: Systems approaches reveal shared pathways affected in SARS-CoV-2 infection and cancer |
Nevan Krogan |
| 456 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-024: Incidence of SARS-COV-2 infection in cancer patients undergoing active treatment |
Celia Martin Bravo, Isabel Blancas López-Barajas, Raúl Quirós López, Marta Robles Lasarte, Rosa Villatoro Roldán, Julia Alcaide García, Victor Navarro Pérez, Diego Perez Martín, Irene Zarcos Pedrinaci, Elisa Mañas Mora, Nicolás Jiménez García, Santiago Vico Cabra, Irati de Urrutia Undabarrena, Isabel Barragan Mallofret, Cristina Quero Blanco, Elisabeth Pérez-Ruiz |
| 457 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S05-03: Preserving innate memory to overcome SARS-CoV-2 infection through the mevalonate pathway |
Juan Luis Gomez, Adam Brufsky |
| 458 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-049: SARS-CoV-2 multiepitope vaccine constructs designed to drive long-term immunity in the majority of the population |
Mark Yarmarkovich, John M. Warrington, Alvin Farrel, John M. Maris |
| 459 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-075: Performance comparison of five extraction kits for SARS-CoV-2 RNA extraction |
Ilinca M. Lungu, Angela De Luca, Jason Li, Jane Bayani, Melanie Spears, Trevor J. Pugh, John M.S. Bartlett |
| 460 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S08-01: Highly sensitive and full-genome interrogation of SARS-CoV-2 using multiplexed PCR enrichment followed by next-generation sequencing |
Chenyu Li, David N. Debruyne, Julia Spencer, Vidushi Kapoor, Lily Y. Liu, Bo Zhou, Utsav Pandey, Moiz Bootwalla, Dejerianne Ostrow, Dennis T. Maglinte, David Ruble, Alex Ryutov, Lishuang Shen, Lucie Lee, Rounak Feigelman, Grayson Burdon, Jeffrey Liu, Alejandra Oliva, Adam Borcherding, Hongdong Tan, Alexander E. Urban, Xiaowu Gai, Jennifer Dien Bard, Guoying Liu, Zhitong Liu |
| 461 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S03-03: A computational approach to identify a possible SARS-CoV-2 vaccine from receptor binding domain peptide sequence on spike glycoproteins |
Majid Al-Zahrani |
| 462 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S03-02: Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T-cell epitopes |
Asaf Poran, Dewi Harjanto, Matt Malloy, Christina M. Arieta, Daniel A. Rothenberg, Divya Lenkala, Marit M. van Buuren, Terri A. Addona, Michael S. Rooney, Lakshmi Srinivasan, Richard B. Gaynor |
| 463 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-043: A prospective testing SARS-Cov-2/COVID-19 in cancer patients with antitumor treatment |
Kathan D. Mehta, Elizabeth Wulf-Burchfield, Natalie Streeter, Anup Kasi, Adam H. AlDouri, Roy Jensen, Andrew K. Godwin, Terry Tsue, Weijing Sun |
| 464 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-018: Hematology oncology COllaborative VIDeoconferencing (COVID) Learning Initiative: A multi-institutional trainee alliance to rapidly disseminate emerging SARS-CoV2 and cancer best practices |
Richard L. Martin, Michael Grant, Rushad Patell, Shonali Middha, Jori May, Charles Bodine, Leo Reap, David Furfaro, Samuel Brusca, Jill Gilbert, Christine Lovly, Frances Collichio, Jennifer Green |
| 465 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2020―Dec―03 |
Abstract PO-032: Virtually SPARCC-ing clinical cancer careers among URM students during a global pandemic |
Kristina Kaljo, Robert Treat, Janet S. Rader |
| 466 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract S07-03: Scientia potentia est: How the Italian world of oncology changes in the COVID19 pandemic |
Zelmira Ballatore, Lucia Bastianelli, Filippo Merloni, Nicoletta Ranallo, Luca Cantini, Lorenzo Mariotti, Claudia Catani, Michela Burattini, Alessandra Lucarelli, Rossana Berardi |
| 467 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-006: Barriers to Virtual Video Connect (VVC) cancer care among southern rural veterans during the COVID19 pandemic |
Philip A. Haddad, Dalia Hammoud, Michelle Phelan, Rosline Wallace-Seamster, Kevin Gallagher |
| 468 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-039: Technology-mediated communication with patients is a challenge for oncologists in the digital and pandemic era… and the winner is WhatsApp! |
Mariangela Torniai, Giulia Marcantognini, Ilaria Fiordoliva, Giulia Mentrasti, Veronica Agostinelli, Alessandra Pagliacci, Rossana Berardi, Michele Caporossi |
| 469 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-072: Doctors and nurses during COVID19 pandemic: A different perception of cancer care |
Lucia Bastianelli, Filippo Merloni, Nicoletta Ranallo, Luca Cantini, Lorenzo Mariotti, Alessandra Lucarelli, Zelmira Ballatore, Rossana Berardi |
| 470 |
[GO] |
Clinical Cancer Research |
2020―Dec―03 |
Abstract PO-010: Changes in lung cancer treatment as a result of the COVID19 pandemic: A prospective observational study |
Suzanne Kazandjian, Nathaniel Bouganim, Arielle Elkrief |
| 471 |
[GO] |
Blood Cancer Discovery |
2020―Nov―04 |
Correction: COVID-19 Infections and Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers |
Malin Hultcrantz, Joshua Richter, Cara A. Rosenbaum, Dhwani Patel, Eric L. Smith, Neha Korde, Sydney X. Lu, Sham Mailankody, Urvi A. Shah, Alexander M. Lesokhin, Hani Hassoun, Carlyn Tan, Francesco Maura, Andriy Derkach, Benjamin Diamond, Adriana Rossi, Roger Pearse, Deepu Madduri, Ajai Chari, David Kaminetzky, Marc J. Braunstein, Christian Gordillo, Ran Reshef, Ying Taur, Faith E. Davies, Sundar Jagannath, Ruben Niesvizky, Suzanne Lentzsch, Gareth J. Morgan, Ola Landgren |
| 472 |
[GO] |
Blood Cancer Discovery |
2020―Nov―02 |
Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19 |
Madhav V. Dhodapkar, Kavita M. Dhodapkar, Rafi Ahmed |
| 473 |
[GO] |
Clinical Cancer Research |
2020―Oct―13 |
Similarities in Risk for COVID-19 and Cancer Disparities |
Lisa Newman, Robert A Winn, John M. Carethers |
| 474 |
[GO] |
Blood Cancer Discovery |
2020―Oct―13 |
Don't Compromise Myeloma Care Due to COVID-19 Pandemic! |
Nikhil C. Munshi, Kenneth C. Anderson |
| 475 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2020―Sep―25 |
Examining COVID-19 Preventive Behaviors among Cancer Survivors in the United States: an analysis of the COVID-19 Impact Survey |
Jessica Y Islam, Marlene Camacho-Rivera, Denise C. Vidot |
| 476 |
[GO] |
Cancer Prevention Research |
2020―Sep―21 |
COVID-19, Cancer Care and Prevention |
Raymond N. DuBois |
| 477 |
[GO] |
Cancer Discovery |
2020―Sep―18 |
Repurposing Cancer Drugs for COVID-19 |
|
| 478 |
[GO] |
Cancer Prevention Research |
2020―Sep―17 |
Disparities in Cancer Prevention in the COVID-19 Era |
John M. Carethers, Rajarshi Sengupta, Rea Blakey, Antoni Ribas, Gypsyamber D'Souza |
| 479 |
[GO] |
Cancer Discovery |
2020―Sep―16 |
Q&A: Solange Peters on COVID-19, Cancer Intersection; Immunotherapy Biomarkers |
|
| 480 |
[GO] |
Cancer Research |
2020―Sep―04 |
Abstract CT405: Experience in using oncology drugs in patients with COVID-19 |
Paolo A. Ascierto |
| 481 |
[GO] |
Cancer Research |
2020―Sep―04 |
Abstract CT402: TERAVOLT (Thoracic cancERs international coVid 19 cOLlaboraTion): First results of a global collaboration to address the impact of COVID-19 in patients with thoracic malignancies |
Marina Chiara Garassino |
| 482 |
[GO] |
Cancer Research |
2020―Sep―04 |
Abstract CT403: Outcome of cancer patients infected with COVID-19, including toxicity of cancer treatments |
Fabrice Barlesi, Stéphanie Foulon, Arnauld Bayle, Bertrand Gachot, Fanny Pommeret, Christophe Willekens, Annabelle Stoclin, Mansouria Merad, Franck GriscelliI, Jean-Baptise Micol, Roger Sun, Thomas Nihouarn, Corinne Balleygier, Fabrice André, Florian Scotte, Benjamin Besse, Jean-Charles Soria, Laurence Albiges |
| 483 |
[GO] |
Cancer Research |
2020―Sep―04 |
Abstract CT406: Patients with cancer appear more vulnerable to SARS-COV-2: A multi-center study during the COVID-19 outbreak |
Meng-Yuan Dai, Dian-bo Liu, Miao Liu, Fu-Xiang Zhou, Gui-Ling Li, Zhen Chen, Zhi-An Zhang, Hua-You Md, Meng Wu, Qi-Chao Zheng, Yong Xiong, Hui-Hua Xiong, Chun Wang, Chang-Chun Chen, Fei Xiong, Yan Zhang, Ya-Qin Peng, Si-Ping Ge, Bo Zhen, Ting-Ting Yu, Ling Wang, Hua Wang, Yu Liu, Ye-Shan Chen, Jun-Hua Mei, Xiao-Jia Gao, Zhu-Yan Li, Li-Juan Gan, Can He, Zhen Li, Yu-Ying Shi, Yu-Wen Qi, Jing Yang, Daniel G. Tenen, Li Chai, Lorelei Ann Mucci, Mauricio Santillana, Hongbing Cai |
| 484 |
[GO] |
Cancer Research |
2020―Sep―04 |
Abstract CT401: The experience of treating patients with cancer during the COVID-19 pandemic in China |
Li Zhang, F Zhu, L Xie, C Wang, J Wang, R Chen, P Jia, H Q. Guan, L Peng, P Peng, P Zhang, Q Chu, Q Shen, Y Wang, S Y. Xu, J P. Zhao, M Zhou, Y Chen |
| 485 |
[GO] |
Cancer Discovery |
2020―Sep―01 |
COVID-19 Challenges Status Quo for Cancer Care |
|
| 486 |
[GO] |
Cancer Discovery |
2020―Aug―19 |
ICI Impact on COVID-19 Severity Modest at Best |
|
| 487 |
[GO] |
Clinical Cancer Research |
2020―Aug―18 |
The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting Impacts |
Alex Broom, Katherine Kenny, Alexander Page, Nicole Cort, Eric Lipp, Aaron C Tan, David M Ashley, Kyle M Walsh, Mustafa Khasraw |
| 488 |
[GO] |
Blood Cancer Discovery |
2020―Jul―31 |
COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers |
Malin Hultcrantz, Joshua Richter, Cara A Rosenbaum, Dhwani Patel, Eric L Smith, Neha Korde, Sydney X Lu, Sham Mailankody, Urvi A. Shah, Alexander M Lesokhin, Hani Hassoun, Carlyn Tan, Francesco Maura, Andriy Derkach, Benjamin Diamond, Adriana Rossi, Roger Pearse, Deepu Madduri, Ajai Chari, David Kaminetzky, Marc J Braunstein, Christian Gordillo, Ran Reshef, Ying Taur, Faith E Davies, Sundar Jagannath, Ruben Niesvizky, Suzanne Lentzsch, Gareth J Morgan, Ola Landgren |
| 489 |
[GO] |
Cancer Discovery |
2020―Jul―31 |
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients. |
David J Pinato, Alberto Zambelli, Juan Aguilar-Company, Mark Bower, Christopher CT Sng, Ramon Salazar, Alexia Bertuzzi, Joan Brunet, Ricard Mesía, Elia Seguì, Federica Biello, Daniele Generali, Salvatore Grisanti, Gianpiero Rizzo, Michela Libertini, Antonio Maconi, Nadia Harbeck, Bruno Vincenzi, Rossella Bertulli, Diego Ottaviani, Anna Carbó, Riccardo Bruna, Sarah Benafif, Andrea Marrari, Rachel Wuerstlein, Maria Carmen Carmona-Garcia, Neha Chopra, Carlo Alberto Tondini, Oriol Mirallas, Valeria Tovazzi, Marta Betti, Salvatore Provenzano, Vittoria Fotia, Claudia Andrea Cruz, Alessia Dalla Pria, Francesca D'Avanzo, Joanne S Evans, Nadia Saoudi-Gonzalez, Eudald Felip, Myria Galazi, Isabel Garcia-Fructuoso, Alvin J X Lee, Thomas Newsom-Davis, Andrea Patriarca, David García-Illescas, Roxana Reyes, Palma Dileo, Rachel Sharkey, Yien Ning Sophia Wong, Daniela Ferrante, Javier Marco-Hernández, Anna Sureda, Clara Maluquer, Isabel Ruiz-Camps, Gianluca Gaidano, Lorenza Rimassa, Lorenzo Chiudinelli, Macarena Izuzquiza, Alba Cabirta, Michela Franchi, Armando Santoro, Aleix Prat, Josep Tabernero, Alessandra Gennari |
| 490 |
[GO] |
Cancer Discovery |
2020―Jul―22 |
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study |
Donna R Rivera, Solange Peters, Orestis A Panagiotou, Dimpy P Shah, Nicole M. Kuderer, Chih-Yuan Hsu, Samuel M. Rubinstein, Brendan J Lee, Toni K Choueiri, Gilberto de Lima Lopes, Petros Grivas, Corrie A Painter, Brian I. Rini, Michael A. Thompson, Jonathan Arcobello, Ziad Bakouny, Deborah B Doroshow, Pamela C. Egan, Dimitrios Farmakiotis, Leslie Anne Fecher, Christopher R Friese, Matthew D Galsky, Sanjay Goel, Shilpa Gupta, Thorvardur R. Halfdanarson, Balazs Halmos, Jessica E Hawley, Ali Raza Khaki, Christopher A. Lemmon, Sanjay Mishra, Adam J Olszewski, Nathan A Pennell, Matthew M. Puc, Sanjay G. Revankar, Lidia Schapira, Andrew Schmidt, Gary K. Schwartz, Sumit A Shah, Julie T Wu, Zhuoer Xie, Albert C. Yeh, Huili Zhu, Yu Shyr, Gary H. Lyman, Jeremy L Warner |
| 491 |
[GO] |
Cancer Discovery |
2020―Jul―15 |
Cancer Research: The lessons to learn from COVID-19 |
Chris Bailey, James R M Black, Charles Swanton |
| 492 |
[GO] |
Clinical Cancer Research |
2020―Jul―02 |
COVID-19 testing in cancer patients: Does one size fit all? |
Ainhoa Madariaga, Michelle McMullen, Semira Sheikh, Rajat Kumar, Fei-Fei Liu, Camilla Zimmermann, Shahid Husain, Gelareh Zadeh, Amit M Oza |
| 493 |
[GO] |
Clinical Cancer Research |
2020―Jun―15 |
Immune-Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era |
Michele Maio, Omid Hamid, James Larkin, Alessia Covre, Maresa Altomonte, Luana Calabrò, Santosha A Vardana, Caroline Robert, Ramy Ibrahim, Andrea Anichini, Jedd D. Wolchok, Anna Maria Di Giacomo |
| 494 |
[GO] |
Cancer Discovery |
2020―Jun―08 |
COVID-19 Delays Cancer Screenings |
|
| 495 |
[GO] |
Clinical Cancer Research |
2020―Jun―05 |
The World of Clinical Trial Development Post-Covid-19: Lessons Learned from a Global Pandemic. |
Fatima Karzai, Ravi A. Madan, William Dahut |
| 496 |
[GO] |
Cancer Discovery |
2020―May―29 |
Registries Offer Insights on COVID-19-Cancer Connection |
|
| 497 |
[GO] |
Cancer Discovery |
2020―May―22 |
The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2 |
Beril Tutuncuoglu, Merve Cakir, Jyoti Batra, Mehdi Bouhaddou, Manon Eckhardt, David E Gordon, Nevan J Krogan |
| 498 |
[GO] |
Cancer Discovery |
2020―May―13 |
The Era of COVID-19 and the Rise of Science Collectivism in Cancer Research |
Tobias Janowitz, David A. Tuveson |
| 499 |
[GO] |
Cancer Discovery |
2020―May―12 |
Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers |
Jia Luo, Hira Rizvi, Jacklynn V Egger, Isabel R Preeshagul, Jedd D. Wolchok, Matthew D. Hellmann |
| 500 |
[GO] |
Cancer Discovery |
2020―May―05 |
Cytokine Storm Drugs Move from CAR T to COVID-19 |
|
| 501 |
[GO] |
Cancer Epidemiology Biomarkers & Prevention |
2020―May―05 |
The COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action |
Andrew T. Chan, David A. Drew, Long H. Nguyen, Amit D. Joshi, Wenjie Ma, Chuan-Guo Guo, Chun-Han Lo, Raaj S. Mehta, SOHEE KWON, Daniel R. Sikavi, Marina V. Magicheva-Gupta, Zahra S. Fatehi, Jacqueline J. Flynn, Brianna M. Leonardo, Christine M. Albert, Gabriella Andreotti, Laura E. Beane Freeman, Bijal A. Balasubramanian, John S Brownstein, Fiona Bruinsma, Annie N. Cowan, Anusila Deka, Michael E. Ernst, Jane C. Figueiredo, Paul W. Franks, Christopher D Gardner, Irene M. Ghobrial, Christopher A. Haiman, Janet E. Hall, Sandra L. Deming-Halverson, Brenda Kirpach, James V Lacey, Loic Le Marchand, Catherine R. Marinac, Maria Elena Martinez, Roger L. Milne, Anne M Murray, Denis Nash, Julie R. Palmer, Alpa V. Patel, Lynn Rosenberg, Dale P. Sandler, Shreela V Sharma, Shepherd H. Schurman, Lynne R. Wilkens, Jorge E. Chavarro, A. Heather Eliassen, Jaime E. Hart, Jae Hee Kang, Karestan C. Koenen, Laura D. Kubzansky, Lorelei A. Mucci, Sebastien Ourselin, Janet W. Rich-Edwards, Mingyang Song, Meir J Stampfer, Claire J. Steves, Walter C. Willett, Jonathan Wolf, Tim Spector |
| 502 |
[GO] |
Cancer Discovery |
2020―May―01 |
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System |
Vikas Mehta, Sanjay Goel, Rafi Kabarriti, Daniel Cole, Mendel Goldfinger, Ana Acuna-Villaorduna, Kith Pradhan, Raja Thota, Stan Reissman, Joseph A. Sparano, Benjamin A Gartrell, Richard V. Smith, Nitin Ohri, Madhur Garg, Andrew D. Racine, Shalom Kalnicki, Roman Perez-Soler, Balazs Halmos, Amit Verma |
| 503 |
[GO] |
Cancer Discovery |
2020―Apr―28 |
Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak |
Mengyuan Dai, Dianbo Liu, Miao Liu, Fuxiang Zhou, Guiling Li, Zhen Chen, Zhian Zhang, Hua You, Meng Wu, Qichao Zheng, Yong Xiong, Huihua Xiong, Chun Wang, Changchun Chen, Fei Xiong, Yan Zhang, Yaqin Peng, Siping Ge, Bo Zhen, Tingting Yu, Ling Wang, Hua Wang, Yu Liu, Yeshan Chen, Junhua Mei, Xiaojia Gao, Zhuyan Li, Lijuan Gan, Can He, Zhen Li, Yuying Shi, Yuwen Qi, Jing Yang, Daniel G Tenen, Li Chai, Lorelei A. Mucci, Mauricio Santillana, Hongbing Cai |
| 504 |
[GO] |
Cancer Discovery |
2020―Apr―24 |
COVID-19 Hits Cancer Research Funding |
|
| 505 |
[GO] |
Cancer Discovery |
2020―Apr―20 |
COVID-19 More Frequent, Severe in Cancer Patients |
|
| 506 |
[GO] |
Clinical Cancer Research |
2020―Apr―20 |
Adapting to a pandemic - conducting oncology trials during the SARS-CoV-2 pandemic |
Aaron C Tan, David M Ashley, Mustafa Khasraw |
| 507 |
[GO] |
Cancer Discovery |
2020―Apr―17 |
Harnessing CAR T Cell Insights to Develop Treatments for Hyperinflammatory Responses in COVID-19 patients |
Sangya Agarwal, Carl H. June |
| 508 |
[GO] |
Cancer Discovery |
2020―Apr―15 |
AACR Calls on Congress to Take Immediate Action Against COVID-19 and Protect Patients with Cancer During the Pandemic |
|
| 509 |
[GO] |
Cancer Discovery |
2020―Apr―10 |
Cancer Care Goes Virtual in Response to COVID-19 |
|
| 510 |
[GO] |
Cancer Discovery |
2020―Apr―10 |
TMPRSS2 and COVID-19: Serendipity or opportunity for intervention? |
Konrad H. Stopsack, Lorelei A. Mucci, Emmanuel S. Antonarakis, Peter S. Nelson, Philip W. Kantoff |
| 511 |
[GO] |
Cancer Discovery |
2020―Apr―01 |
Clinical Research Slows as COVID-19 Surges |
|
| 512 |
[GO] |
Cancer Discovery |
2020―Mar―31 |
Cancer Labs Pivot to Battle COVID-19 |
|
| 513 |
[GO] |
Cancer Discovery |
2020―Mar―24 |
COVID-19 Challenges Basic Researchers |
|
|
